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ABSTRACT 
Nanomaterials are promoted as a promising technology in highly diverse 
applications, but concerns about risks of  these materials have stimulated extensive 
research on the adverse effects  of  manufactured  nanoparticles. Our research utilized ex 
vivo tissues to study quantification  of  unlabeled nanoparticles in biological media and in 
vitro cultures of  human cells, treated with suspensions of  low-solubility metal oxide 
materials, to study uptake, cell signaling, and gene regulation. The effects  of 
nanoparticles on the cardiovascular system occur because inhaled nanoparticles may 
enter systemic circulation, or are directly injected into systemic circulation for  medical 
applications, causing adverse health effects.  Silicon dioxide (Si02) particles with sizes 
between 20-100 nm were used in our studies because they have many commercial and 
medical applications and can be readily modified  with surface  functional  groups. Our 
hypothesis is two-fold.  First, we hypothesize that tissue uptake and deposition of  Si02 
nanoparticles can be measured by sedimentation field-flow  fractionation  (SdFFF) after 
particle isolation using enzyme digestion. We also hypothesize that the adverse effects 
associated with nanoparticle exposures are greater in vascular cells than pulmonary and 
colorectal cell lines, due to the formation  of  reactive oxygen species, which may 
stimulate apoptosis. The results presented here demonstrate the cellular uptake of  nano 
and submicron-sized Si02 using the traditional methods of  microscopy. Additionally, the 
method of  SdFFF, which is typically used to separate macromolecules, colloids, and 
particles, was used in combination with enzyme digestion to provide a novel, useful 
method to simultaneously measure both the size and concentration of  particles in tissues. 
The toxic effects  of  metal oxide particle treatment on vascular, pulmonary and colon cells 
were evaluated. Significant  cytotoxicity and inflammation  were observed with vascular 
endothelial cells, but little to no adverse effects  were seen in pulmonary and colon cancer 
epithelial cells at concentrations of  1-316 pg/cm2. Nano-sized SiC>2 caused apoptosis in 
vascular endothelial cells that was ameliorated by pretreatment with 5 mM of  the 
antioxidant, N-acetyl-L-cysteine. Our results show that exposures of  endothelial cells to 
high concentrations of  nano-sized Si02 may have serious adverse cardiovascular 
consequences. Furthermore, these results provide insights into treatments, such as the 
use of  antioxidants, for  persons exposed to significant  levels of  metal oxide nanoparticles. 
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Definition  of  a Nanoparticle 
The SI (international system of  units) definition  of  nano is a prefix  used to form 
decimal submultiples of  the SI unit "meter", designating a factor  of  10"9 denoted by the 
symbol "n". The word particle is defined  as a small object that behaves as a whole unit in 
terms of  its transport and properties. However simply combining these two terms together 
does not truly define  a nanoparticle. According to the American Society for  Testing and 
Materials (ASTM), an international standards organization, a nanoparticle is a sub-
classification  of  ultrafine  particle with lengths in two or three dimensions greater than 1 nm 
and smaller than 100 nm, which may or may not exhibit size-related properties [1]. This 
definition  is based on the field  of  nanotechnology. However, since the study of  nanoparticles 
is interdisciplinary, the term nanoparticle is often  confused  with other terminology such as 
ultrafine  particles (UFP) and nucleation mode particles [2]. Oberdorster et al. reviews the 
classification  of  nanoparticles based on size and origin as viewed by a toxicologist, an 
atmospheric scientist and a material scientist [3]. Since the term nanoparticle is so complex, 
the definition  of  a nanoparticle used henceforth  will be based on size as defined  by the 
ASTM where particles smaller than 100 nm are called nanoparticles (NPs). 
2 
Source of  Nanoparticle Production 
Incidental and Environmental 
The source of  nanoparticle production can be classified  as either 
incidental/environmental or anthropogenic/manufactured.  Incidental and environmental 
particles are the principle components of  air pollution. Studying the effects  of  air pollutants 
is a major focus  of  the Environmental Protection Agency (EPA) because of  a growing link 
between air pollution and morbidity and mortality. The first  piece of  evidence linking air 
pollution and mortality was in the Meuse Valley in 1930, where during a pollution episode, 
60 people died within 3 days [4], The "London Fog" of  1952 provided additional 
epidemiological data correlating mortality and air pollution [5]. More recently, the National 
Mortality and Morbidity Air Pollution Study (NMMAPS) of  the 90 largest U.S. cities, 
estimated that the daily total and cardiopulmonary mortality increased in the short term by 
0.21% (±0.06 standard error (SE)) and 0.31% (±0.09 SE), respectively, for  each 10 pg/m3 
increase in coarse particulate matter (PMio) measured over a 24-hour period [6]. Because 
24-hour PMio concentrations within the U.S. range from  a low of  24 to a high of  719 pg/m3 
[7], cumulative risk from  particulates can be substantial in some regions of  the country. 
Air pollution consists of  a heterogeneous mixture of  gases, (NO2, CO, SO2 and 
ozone) and particulate matter (PM). Suspended particles are generally separated into coarse 
(PM10-2.5), fine  (PM2.5) and ultrafine  (PM0.i) fractions  [8]. Primary particles in air pollution 
are emitted directly into the environment, but secondary particles, such as nitrates and 
sulfates,  are formed  from  gaseous nitric acid and sulfur  dioxide. PM10-2.5 arise almost 
exclusively from  natural sources, like windblown soil, and from  other sources like tire 
fragmentation,  resuspension of  road dust, smelting, processing, agriculture, construction and 
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demolition activities, pollens, molds and volcanic emissions. PM2.5 and PM0.i particles arise 
almost exclusively from  combustion, and are comprised of  motor vehicle emissions, power 
generation and other industrial combustion products (including smelter emissions), and 
residential wood burning and forest  fires.  A study of  the air in Houston was performed  to 
determine exposures of  the population on a daily basis [9]. The results show particulates 
such as carbon black (CB), which is often  used as a surrogate for  combustion soot, and many 
other particulates were present in the air. Interestingly, they found  that nano-sized silica, not 
typically found  in the air, was also present. The source of  nanosilica in the air is most likely 
from  an incineration process or perhaps through thermal decomposition of  silane [10], 
Anthropogenic and Manufactured 
With the advances in technology and the attractiveness of  nanoparticle chemistry, 
scientists have begun to introduce nanoparticles into various scientific  fields.  Already there 
are over 600 manufacturer-identified  consumer products incorporating nanotechnology [11]. 
A few  of  the current and future  uses for  nanoparticles are summarized in Table 1.1. The 
National Nanotechnology Initiative (NNI) was developed by the National Science and 
Technology Council (NSTC) to coordinate science and technology policy at the level of  the 
Federal Government. The NNI has identified  and outlined the needs for  research related to 
environmental health and safety  of  nanomaterials. Their strategy for  nanotechnology 
research is outlined in a report by the NSTC [12]. In general the federal  government has 
realized the growing use of  nanomaterials and has developed an agency to oversee and 
regulate funding  for  the advancement of  the environmental health and safety  of 
nanoparticles. 






• Bio-detection and labeling 
• Bio-magnetic separations 
• Drug delivery 
• MRI contrast agents 
• Orthopedics and implants 
• Sunscreens 
• Thermal spray coatings 
• Automotive catalyst 
• Ceramic membranes 
• Fuel cells 
• Photo-catalysts 
• Propellants 
• Scratch-resistant coatings 
• Structural ceramics 
• Solar cells 
Metal Oxide Nanoparticles 
Metal oxides comprise a very important category of  nanoparticles which can impact 
human health through environmental and manufactured  processes [13]. Metal oxide 
nanoparticles can be prepared with extremely high surface  areas and can form  unusual crystal 
structures that have multiple reactive surface  features,  including edges and corners [14]. 
These reactive surfaces  can facilitate  interesting reactions, e.g., methane activation, D2-CH 
exchange, CO oligomerization, oxygen exchange in CO2 and H2O [15]. The nanostructures 
of  metal oxides can exhibit an electronic arrangement that can display metallic, 
semiconductor, or insulator characteristics. Insulating oxides contain metals from  Groups I, 
II and XIII-XVII of  the periodic table (MgO, CaO, A1203, and Si02), while semiconducting 
or metallic oxides contain metals from  groups III-XII of  the periodic table (ZnO, Ti02, NiO 
Fe203 and C^Oa). Transitional metal oxides (Ru, Mo, W, Pt, V) are used as catalysts and 
sensor materials [15]. Applications for  metal oxides include fabrication  of  microelectronic 
circuits, sensors, piezoelectric devices, fuel  cells, coatings for  the passivation of  surfaces 
against corrosion, and catalysts [13]. 
Drug Delivery 
In addition to their use as components of  electronics, metal oxides are useful  in the 
biomedical field  as vehicles for  drug [16-18] and gene [19, 20] delivery, as well as imaging 
probes [21] and as disease diagnostic tools. Use of  these and other particulates in the 
biomedical field  has spawned a new term, nanomedicine. Nanoparticles were chosen for  use 
in the medical field  because of  their unique properties, which make them different  from  the 
corresponding bulk materials of  the same chemical composition. A notable difference 
between micron and nano-sized particles is their surface  area per mass. Klabunde et al. 
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compare surface  atoms and bulk atom ratios that are based on particle size, to show that 
spherical nanoparticles (less than 3 nra) have more of  the atoms or ions on their surfaces 
[14]. Due in part to the large and reactive surface  areas of  nanoparticles, drugs can be 
conjugated to their surface  to achieve high concentrations and site-specific  dosing [3]. Being 
able to conjugate drugs to the particle surface  permits for  high concentrations of  drug to be 
delivered to a specific  site. However, an additional benefit  of  nanoparticles is that their 
increased surface  reactivity can lead to increased uptake and interactions with biological 
tissues [22], This method of  drug delivery would be less interesting if  the particle-drug 
conjugates were not able to enter the tissue of  interest. 
The properties that make nanoparticles attractive carriers also increase their toxicities. 
The increased surface  area and reactivity means the particles can adsorb other particles, 
proteins or chemicals on their surface,  which changes their interactions with cells. Increased 
uptake may be desirable if  the particle reaches the right location for  drug delivery. However, 
the particle may enter other tissues and cause toxicity. Only a limited number of  studies have 
investigated the interactions of  nanoparticles, used in the medical field,  with human-derived 
cells, so the potential for  toxicity is not well understood. Evidence from  air pollution-
focused  studies show that insoluble nano-sized particles can translocate from  the lung to the 
blood stream [20, 23, 24] and can causes adverse cardiovascular effects  resulting in 
morbidity and mortality in susceptible populations [6, 25]. 
Doses of  injected particles in the vasculature for  biomedical purposes will be much 
higher than air pollution exposures. The interaction between Si02 and the heart and blood 
vessels may compromise this organ system. Previous studies by Martin et al. [26] showed 
acute toxicities in mice after  an injection of  micron sized Si02 particles used in drug delivery. 
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Showing minor toxicities in healthy mice is the first  step for  assessing particle safety, 
however persons receiving these drug treatments are most likely not healthy. The effects  of 
these drug conjugates in a compromised animal model would simulate the responses of 
individuals in different  diseases states. Scientists who study drug delivery with conjugated 
nanoparticles recognize the potential for  adverse events and are slowly working to ensure 
toxicities are identified  before  the therapy is introduced to patients [27]. In fact,  Kim et al. 
examined the toxicity and tissue distribution of  silica-overcoated magnetic nanoparticles 
injected into mice. Particles were found  in most organs of  the mouse but no significant 
toxicities were identified  by analyzing markers in the serum [28]. In contrast to product-
specific  safety  testing, such as needed to plan clinical trials, research focusing  on the 
fundamental  molecular mechanisms of  particle interactions with cells is needed. In more 
mechanistic studies, Chen et al. reported human epithelial cell uptake and translocation of 
nano-sized silica particles to the nucleus where the particles induced formation  of  aberrant 
clusters containing proteins that are important in gene regulation [29]. Furthermore, silica-
nuclear protein clusters were shown to inhibit replication, transcription, and cell proliferation 
[29]. Mechanistic understanding of  particle-vascular cell interactions can help predict 
adverse events that may occur and can guide development of  biocompatible formulations. 
Exposure 
Exposure to nanoparticles can vary depending upon the particulate source. Dermal 
exposures are often  intentional through the application of  sun screen, which contains zinc 
oxide (ZnO) and/or titanium dioxide (TiC^), and topical cosmetics. However, dermal 
absorption of  these particles has yet to be established since the skin provides a thick 
protective barrier [30]. Ingestion, exposing the gastrointestinal tract (GI), is another common 
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route of  exposure. Ingestion can be accidental due to ingestion of  topically applied 
nanoparticles, foods  that use nanoparticles such as Ti02 as food  additives [31] to improve 
food  flavor,  color, or texture or by clearing inhaled particles from  the lung by coughing 
followed  by ingestion. Injection of  particles into the systemic circulation is most often 
related to the use of  nanoparticles for  biomedical purposes. However, translocation of 
particles into systemic circulation leads to vascular exposure. The most common route of 
exposure is by inhalation (respiratory tract). A source of  inhaled nanoparticles is from  air 
pollution but can also be from  inhaled drugs using nanoparticles as drug carriers. 
Uptake and Translocation 
All fractions  of  inhaled particulates are capable of  reaching the respiratory tract. 
Figure 1.1 graphically represents the alveolar space in the lung drawn to scale. Particles are 
drawn in the alveolar air space at sizes from  10 nm to 5 pm. It becomes clear that larger 
particles would tend to deposit in the upper respiratory tract and tracheobronchial regions, 
and small particles (PM2.5) would show greater deposition in lower airways. Ultrafine  or 
nano-sized particles (PM0.1) are short-lived because of  a tendency to coalesce, but deposit in 
the tracheobronchial and alveolar regions and are, therefore,  potentially the most toxic. The 
graph in the bottom corner of  Figure 1.1 depicts the deposition of  particles based on size in 
the alveolus; the smaller the particles, the higher the deposition. 
As shown in Figure 1.1, nanoparticles are very small relative to the alveolar epithelial 
cells, and are believed to enter the systemic circulation from  the lung [22, 24, 32-35]. 
Current hypotheses for  the method of  translocation are as follows:  1) cell mediated active 
transport via phagocytosis (macrophages) and/or endocytosis (alveolar epithelial or 
endothelial cells), 2) passive transportation/diffusion,  or 3) by active or passive transport 
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Figure 1.1 Deposition of  particles in the lung. Reproduced with permission from  John Veranth (Copyright 2000). 
through pores (caveolae) in the cytoplasm of  endothelial cells or between epithelial cells (gap 
junctions) [36]. 
Monitoring human exposure to engineered nanoparticles (from  air, water, food, 
consumer products, and soil), determining the rate of  particle uptake by humans and food 
chain organisms, and measuring the resulting nanoparticle concentrations in target organs are 
major challenges for  nanoparticle toxicology studies [37], Most nanoparticle uptake and 
translocation research has quantified  nanoparticles in vivo using some type of  unique particle 
label. Kreyling et al. showed translocation of  15- and 80-nm radio-labeled iridium particles 
in rats with deposition outside of  the lung being less than 1% [24]. Sadauskas et al. used 
trace metals such as gold and iridium [38], and Ryman-Rasmussen et al. used fluorescent 
particles [39] to determine particle translocation. However, the population exposures most 
relevant to health of  the general population involve the emissions or deliberate release of 
high-production-volume manufactured  nanomaterials and exposures to incidental 
nanoparticles, such as soot. Combustion emissions and manufactured  powders such as 
fumed  silica, ultrafine  TiC>2, and similar industrial materials rarely have a unique and easily 
detected label. 
Without using a unique label, Geiser et al. showed that 22 nm Ti02, instilled into rats, 
was found  on the luminal side of  airways and alveoli, in all major lung tissue compartments 
and cells, and within capillaries, using energy filtering  transmission electron microscopy 
(TEM), [22]. Furthermore, Elder et al. used elemental analysis to show the presence of 
inhaled 30 nm manganese particles in neural tissue [40]. Measuring changes in the 
concentration of  unlabeled particles in tissue with these techniques is difficult.  Extracting 
quantative information  from  TEM images is inexact and elemental analysis does not 
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distinguish particles from  soluble forms  and provides no information  on particle size. A 
more quantitative and qualitative method is needed to determine particle deposition. 
A promising method to measure size and concentration of  unlabeled nanoparticles is 
through separation by field-flow  fractionation  (FFF), which was first  developed in the 1960s 
for  separating macromolecules, colloids, and particles [41, 42], FFF has been used for  the 
measurement of  numerous properties of  macromolecules and colloidal particles, including 
particle mass, size, and density. Caldwell et al. reported seminal work applying FFF to 
detect protein-based particles in eye lens cataracts [43]. FFF has been used to characterize 
natural aquatic colloids [44-46], and perform  size separation of  single-walled carbon 
nanotubes [47]. 
FFF is similar to chromatography methods in that materials are separated by transport 
velocity, but in place of  a retention media the separation is carried out in a thin, open channel 
with bulk flow  in the longitudinal direction and a separation field  (centrifugal  force,  electric 
field,  thermal gradients, or cross-flow)  in the perpendicular direction. Particles are driven to 
the wall by the separation field  and average particle distance from  the wall is determined by 
the competition between the separation field  and the size-dependent diffusion  of  particles 
against the concentration gradient. Since the narrow channel has a parabolic flow  profile 
(laminar flow),  the particles farthest  from  the wall are in the highest velocity streamlines and 
therefore  travel the fastest.  Figure 1.2 demonstrates separation of  particles using FFF. With 
normal FFF as shown in figure  1.2, smaller particles elute first  because they are furthest  from 
the collection wall and in the fastest  field  of  the carrier fluid  flow  velocity. Sedimentation 
FFF (SdFFF) uses centrifugal  force  to generate the separation field.  Figure 1.3 depicts an 
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Figure 1.2 Separation of  particles by FFF. Normal FFF, used to describe the separation of 
particles with a diameter of  less than 1 pm. Smaller particles elute first.  Reprinted with 
permission of  Wiley-Liss, Inc. a subsidiary of  John Wiley & Sons, Inc. [42] 
Figure 1.3 Sedimentation FFF (SdFFF) instrumentation. Reprinted with permission of 
Wiley-Liss, Inc. a subsidiary of  John Wiley & Sons, Inc. [42] 
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SdFFF instrument. The minimum detectable particle size depends on the particle density and 
the maximum centrifugal  force  of  the SdFFF instrument [48, 49]. Giddings provides a full 
derivation of  the governing equation and a graph of  minimum resolvable diameter versus 
GAp for  a typical instrument channel geometry [50]. For example, silica particles with a 
density of  2.0-2.65 g/ml, particles as small as -22 nm can be separated using a SdFFF 
instrument's maximum centrifugal  force.  For denser particles such as gold, applying the 
same field  can separate particles as small as 10 nm. Multiple detection techniques can be 
used simultaneously with FFF, including fluorescence,  ultra-violet absorption, light 
scattering, and inductively coupled plasma mass spectroscopy (ICP-MS). The advantage of 
coupling the FFF instrument to ICP-MS is the enhanced sensitivity of  the detector as well as 
its capability to determine the composition of  the particles collected. 
Dosimetry 
Calculating the theoretical concentration of  particle exposure in vivo and 
extrapolating this to an in vitro dose is very complicated. Methods for  in vivo dose 
calculation can be found  in Veranth et al. [51]. Veranth et al. estimated the inhaled volume 
of  particulates to be 10 m3/day for  high environmental exposures and a reasonable 
concentration for  occupational exposure [51]. The deposition of  nanoparticles in the lung is 
estimated at about 60% based on ICRP estimates [52]. The calculated dose based on the area 
of  the lung (70 m [53]) is 0.08 ng/cm . As stated earlier, particles of  different  sizes deposit 
in different  areas of  the lung leading to the accumulation of  particles at high concentrations 
in certain areas of  the lung [54], Figure 1.4A shows the estimated particle dose based on the 
known average volume of  the lung and the assumption based on exposure. The range is from 
0.08 ng/cm2 (based the calculated inhaled exposure) to 80 ng/cm2 which takes into account 
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uncertainties of  deposition, and airflow,  with high concentrations of  particles depositing in 
certain sites of  the lung. Figure 1,4B depicts the same data plotted based on the average 
volume of  lung surfactant. 
The same analysis was performed  based on the dose of  particles in the blood, either 
from  translocation from  the lung (estimated at less than 1% [24]) or from  injection as drug 
carriers or imaging agents. Doses based on translocation are relatively small, however doses 
used for  MRI contrast agents and chemotherapy drugs would be much higher. Ingestion and 
dermal exposures are also shown. Figure 1.4 shows these estimated values. 
Dosimetry as discussed so far  has focused  on in vivo exposures. The extrapolation of 
these doses to a survey of  previous in vitro study doses is represented as the gray bars in 
Figure 1.4. The doses of  particles used for  in vitro studies are often  higher than the plausible 
dose in regards to area dose and more reasonable for  a per volume dose. Many assumptions 
are made to simplify  the calculations of  both exposures. For in vitro studies using cell 
culture models, one of  the main artifacts  that differ  from  in vivo studies is settling velocity 
which may alter the actual dose that the cell encounters. For in vivo studies, particle 
deposition may occur in the lung, however for  other tissues, particles are being carried by the 
blood, over the endothelial cells and may further  deposit in multiple target (vascularized) 
tissues. In cell culture, particles are suspended in culture medium and allowed to settle, 
diffuse,  agglomerate onto the cells. For this reason, Teeguarden et al. introduced the term 
particokinetics [55]. The properties that determine the particokinetics of  a particle in culture 
medium are as follows:  media density and viscosity as well as particle size, shape, charge 
and density. The dose of  the particle that interacts with the cells is likely determined by these 

























Figure 1.4 Plausible particle exposure concentrations. In  vitro concentrations are 
represented as a gray bar. Redrawn from  data in Veranth et al. [51]. 
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particles to travel 1 mm by settling and diffusion  [55]. It is estimated that 50-nm silica 
nanoparticles would take 17 days to settle to the bottom of  a culture dish interacting with 
cells, however cytotoxicity has been shown at 24 hours. The toxicity of  particles often 
assumes direct contact of  the particles with the cells, however toxicity may be due to 
interactions with dissolved molecules from  the surface  of  the particle. Over time, depending 
on the rate of  settling and diffusion,  the interaction of  particles with cells will increase 
leading to enhanced particle effects.  Lison et al. tested the particokinetics theory using 
Stober nanoparticles, which are soluble and do not settle according to the 
diffusion/gravitational  settling model of  Teeguarden et al. [55] and still showed significant 
cytotoxicity at 24 hours [56]. Therefore,  they believe that the nominal dose and particle 
concentrations are the most important determinants of  cellular effects,  not the effects  of 
settling [56]. 
The theory of  particokinetics is relatively new. However it may explain the 
differences  between in vitro particle research between laboratories that utilize slightly 
different  methodologies. Standardization in the field  of  particle toxicology is therefore 
needed. Further understanding of  particokinetics can aid in the comparison of  existing 
toxicology studies. 
Medical and Molecular Consequences of  Exposure 
Toxicity and Inflammation 
Cytokines are soluble peptides that regulate many signal transduction pathways, cell 
growth, differentiation,  and apoptosis, as well as recruitment signals for  neutrophils, 
macrophages, and other mobile cells to specific  sites [57]. Cytokines exert their regulatory 
effects  by binding to specific  receptors belonging to the cytokine superfamily  [57]. The 
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function  of  each cytokine varies but they all play an integral role in the coordination and 
persistence of  inflammatory  processes. The majority of  toxicology studies are based on air 
pollution exposures. Particulates found  in ambient air pollution have been shown to induce a 
lung inflammatory  response in humans [58, 59] characterized by direct activation of  nuclear 
factor-KB  (NF-KB) in the airway epithelium [60, 61], with increased expression of 
intracellular adhesion molecule-1 [61] and enhanced production of  interleukin-ip (IL-1|3) 
[62], interleukin-6 (IL-6) [60-62], interleukin-8 (IL-8) [58, 61, 62], leukemia inhibitory factor 
(LIF) [62] and granulocyte macrophage colony-stimulating factor  (GM-CSF) [62], 
Particulates also secondarily prime a pro-inflammatory  response in lung epithelium by 
inducing secretion of  tumor necrosis factor-a  (TNF-a) by alveolar macrophages [63]. 
Pulmonary deposition of  particulates stimulates bone marrow monocyte release [64] and 
facilitates  experimental thrombosis [65] in animals. In healthy humans, particulate exposure 
increases blood fibrinogen  levels [58] and C-reactive protein (CRP) [66] and causes acute 
arterial vasoconstriction [67]. Thus, inflammatory  mediators produced locally in the lung by 
inhalation of  particulates readily spill over into the systemic circulation from  the pulmonary 
circulation. Considering the important role inflammation  plays in the pathogenesis of 
atherosclerosis [68] and acute plaque rupture, leading to coronary thrombosis [69], it is not 
surprising that one of  the major consequences of  particulate air pollution exposure is an 
increase in both short- and long-term cardiovascular events and mortality [25]. Figure 1.5 
shows the proposed mechanisms by which NPs may lead to cardiovascular dysfunction. 
Pulmonary inflammation,  which has already been described, can cause systemic 
inflammation  leading to the activation of  platelets and leukocytes as well as activation of  an 
acute phase response. Particles may also translocate and directly interact with the 
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vasculature leading to local inflammation.  Furthermore, inhaled particles may alter the 
autonomic nervous system. Particulate exposure has been shown to increases the risk of  ST-
segment depression, a measurement of  the repolarization of  the ventricles of  the heart, during 
submaximal exercise testing; suggesting that exposure to air pollution particles contributes to 
myocardial ischemia in subjects with coronary disease [70]. Particulate exposure by 
inhalation also appears to trigger myocardial infarction  in susceptible individuals [71], 
consistent with the development of  a pro-inflammatory,  pro-coagulant systemic state. In 
addition, disturbances of  cardiac rhythm are precipitated by particulates, placing subjects 
with cardiac arrhythmias at risk. Clearly, particulate air pollution represents an important 
challenge to those concerned with protecting public health. 
Apoptosis and ROS 
To understand the mechanism by which particles alter cellular functions,  the 
endpoints of  apoptosis and its relationship to reactive oxygen species (ROS) will be 
examined. Apoptosis is classically defined  as programmed or "planned" cell death that is 
part of  normal homeostasis. This mode of  cell death occurs in an organized manner, 
resulting in adjacent cells engulfing  and degrading packaged contents of  the dying cell. 
Inflammation  is not caused by apoptosis as it is for  methods of  cell death leading to necrosis, 
which is "unplanned" and "unorganized" resulting in the uncontrolled release of  cellular 
contents. The activation of  apoptosis can occur through external or internal pathways. 
Extracellular signals can include: hormones, growth factors,  nitric oxide, and cytokines, and 
therefore  must either cross the plasma membrane or activate cell membrane signal 
transduction cascades to elicit a response [72]. Intracellular apoptotic signaling is initiated 

































Figure 1.5 Proposed pathway of  cardiovascular toxicity of  NPs. 
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Determining the cause of  apoptosis, be it activation of  the internal or external 
pathway, may give insight into the mechanism by which particles cause cell death. Many 
pro-death stimuli are closely associated with mitochondrial function.  Bcl-2 proteins on the 
surface  of  the mitochondria detect damage, and activate Bax proteins, which destabilize the 
mitochondrial membrane, causing cytochrome c to be released. Cytochrome c binds to 
apoptotic protease activating factor-1  (Apaf-1)  forming  an apoptosome [73]. The 
apoptosome binds to and activates caspase-9 and the caspase cascade, which cleaves the 
proteins of  the mitochondrial membrane, causing it to break down and start a chain reaction 
of  protein denaturation and eventually phagocytosis of  the cell [73], Activation of  the 
various caspases is not solely through mitochondrial release of  cytochrome c. Activation of 
cellular receptors, such as the TNF-a receptor, activates caspase-8 [72], The complete 
signaling pathway for  apoptosis is too complicated to be reproduced here, but has been 
reviewed by Kumar [74]. 
The methods for  detecting apoptosis focus  on the cellular alterations being induced. 
These techniques include measuring mitochondrial versus nuclear DNA degradation, 
detecting morphological changes via microscopy, determining DNA damage, assessing 
alterations in nuclear chromatin, analyzing changes in mitochondrial transmembrane 
potential, measuring the externalization of  phosphatidylserine (PS), measuring DNA strand 
breaks, analyzing sphingolipids, and measuring caspase activation [72]. The best technique 
to use is debatable and the majority of  the time these techniques are used in combination. 
The technique that will be used in this dissertation is the measurement of  PS externalization, 
one of  the early changes that occur during apoptosis. Externalization of  PS has not been 
linked directly to the activation of  the internal or external pathways. What is known is that 
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externalization is regulated by calcium-dependent phospholipid scramblase activity and 
inactivation of  aminophospholipid translocase [75]. The externalization of  PS is responsible 
for  the recruitment signal for  phagocyte docking and subsequent engulfment  and degradation 
of  apoptotic cells. Assaying apoptosis with this technique is therefore  useful  for  determining 
if  cells are undergoing apoptosis. Assays focusing  on more mechanistic aspects of  apoptosis 
such as external versus internal pathway activation will determine the cause of  apoptosis. 
Reactive oxygen species are ions or small molecules that include hydroxyl ( OH), 
alkoxyl (RO ), peroxyl (ROO ), superoxide (0 2 ) and nitroxyl radicals (NO ). Non-radical 
ROS include hydrogen peroxide (H2O2), organic hydroperoxides (ROOH) and hypochlorous 
acid (HOC1). Oxygen-derived free  radicals are generated during many naturally occurring 
cellular processes such as oxidative metabolism and energy production [76]. Reactive 
oxygen species are also produced in response to cytokines or growth factors  and are involved 
in regulation of  signal transduction, gene expression, activation of  receptors and nuclear 
transcription factors,  and oxidative damage to cell components [76]. ROS are implicated in 
many disease processes such as cancer, aging and age related degenerative diseases such as 
Alzheimer's disease [77-79] and cardiovascular diseases such as atherosclerosis [80], 
Antioxidants are often  treatments for  diseases where ROS are involved. Common 
antioxidants include Vitamin C, Vitamin E, glutathione, and melatonin. Other mechanisms 
for  detoxifying  ROS are cellular enzymes. These proteins include superoxide dismutase 
(SOD), NAD(P)H:quinone oxidoreductase (NQOl), catalase and peroxiredoxins. 
Antioxidants detoxify  reactive oxygen species by removing free  radical intermediates, and 
inhibit further  oxidation reactions by being oxidized themselves. Garewal provides a review 
of  antioxidants used in disease prevention [81]. 
Other causes of  ROS production is exposure to particulate matter. The surface  of 
particles themselves can be reactive producing ROS either intracellularly or extracellulary 
[82-85]. In addition to the capacity of  particles to produce ROS directly, cellular systems 
produce ROS in the presence of  particles. When particles are inhaled, immune cells are 
activated, responding to particles as foreign  bodies leading to the production of  inflammatory 
mediators as well as ROS [86]. Furthermore, particles are known to adsorb proteins and 
other chemicals which may enhance their uptake or contact with cell [86]. Other 
mechanisms of  particle-induced ROS formation  are currently under investigation. 
Oxidative stress is often  viewed as a component in the inflammatory  response 
signaling cascade and the stimulation of  adhesion molecules and chemoattractant production 
[76]. Furthermore, ROS has been linked to apoptosis. An early study by Pierch et al. 
showed that treatment of  cells with H2O2 induced apoptosis that was prevented by pre-
treatment with catalase, an enzyme that catalyzes the decomposition of  H2O2 [87]. A 
common link between both ROS and apoptosis is TNF-a [88]. Stimulation of  the TNF-a 
receptor leads to the activation of  caspase-8, which leads to apoptosis. Cytokines such as 
TNF-a are known to trigger ROS production, which acts as a mediator of  many cellular 
responses including apoptosis [89], transcriptional factor  activation [90], calcium spark 
activation [91], and insulin signaling [92]. ROS is believed to oxidize mitochondrial pores 
leading to the release of  cytochrome c, a key signal in apoptosis [93]. The link between ROS 
and apoptosis is clear, however the role particulates have in both of  these pathways is still 
under investigation. Progress has been made to understand the connection, but the focus  has 
been on micron-sized crystalline silica and its role in silicosis. Amorphous silica, which is 
more relevant to medical applications and to many new occupational exposures, does not 
have the same reactive structure of  crystalline silica, and therefore  further  investigation into 
the causes of  silica-induced apoptosis and its link to ROS requires additional careful 
investigation. 
Research Objectives 
With the increased production and use of  nanoparticles, research into their safety  is 
vital. Currently, there is no clear method to determine organ-specific  exposures to adsorbed, 
inhaled, ingested or injected nanoparticles in their natural state. The technologies that do 
exist can be labor intensive and may yield only limited information  about particle 
concentrations, sizes, and compositions. Many in vitro studies are being performed  to assess 
the safety  of  particles after  inhalation. It is only recently that particle toxicologists have 
begun to look outside of  the lung for  tissue damage to other organs. Current research studies 
are difficult  to compare due to experimental variables such as particle composition, or 
variable assay protocols. Particle exposures have been correlated to increased morbidity and 
mortality in the population, so the mechanisms by which particles elicit cellular alterations 
are being avidly investigated. A clear mechanism has yet to be defined. 
The studies presented here will describe a technique for  the analysis of  unlabeled 
particles, determine cellar responses to particulates, and identify  a putative mechanism of 
particle-induced cellular damage. Chapter 2 addresses the problem regarding the 
measurement of  unlabeled inorganic nanoparticles by using SdFFF in combination with 
existing methodologies to determine particle concentration, size and composition. Chapter 3 
describes a series of  cell experiments that compare and contrast vascular, pulmonary and 
colon cell responses to metal oxide particles. These studies use well defined  specific  stocks 
of  particles to carry out all experiments to permit direct comparisons of  particle types in 
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different  cell lines with minimal variables. Chapter 4 addresses the important question of  the 
mechanism by which particles induce cellular responses by investigating the role of  ROS in 
particle-induced apoptosis. Conclusions from  this work are represented in Chapter 5. 
CHAPTER 2 
A NOVEL METHOD TO DETECT UNLABELED INORGANIC 
NANOPARTICLES AND SUBMICRON PARTICLES IN 
TISSUE BY SEDIMENTATION FIELD-FLOW 
FRACTIONATION 
Introduction 
In this chapter, a novel methodology to detect unlabeled inorganic nanoparticles will 
be demonstrated leading to a publication in Particle  and  Fibre  Toxicology.  This method uses 
SdFFF technology, as described in Chapter 1, in conjunction with already existing 
techniques, to detect a mixture of  nano-sized (70 nm) and submicron (250 nm) silicon 
dioxide particles isolated from  cell culture and mammalian tissue. 
Current nanoparticle research has quantified  nanoparticles in vivo using some type of 
unique particle label (fluorescence,  radioactivity, or rare elements) to provide important 
information  regarding nanoparticle uptake and translocation. However, most nanomaterials 
that are commercially produced for  industrial and consumer applications do not contain a 
specific  label. Alternatively, unlabeled inorganic nanoparticle amounts have been measured 
with techniques such as electron microscopy and elemental analysis. However, measuring 
changes in the concentration of  unlabeled particles in tissues with these techniques is 
difficult.  Extracting quantitative information  from  TEM images is inexact and elemental 
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analysis does not distinguish particles from  soluble forms  and provides no information  on 
particle size. 
Initial experiments presented in this chapter employed both fluorescence  and electron 
microscopy because of  their usefulness  in the field  of  particle toxicology. Although other 
techniques are shown, this chapter will focus  on SdFFF of  nanoparticles isolated from 
mammalian tissue and cell culture via acid and enzyme digestion. The goal of  these studies 
was to precisely identify  unlabeled metal oxide nanoparticles and unambiguously distinguish 
nanoparticles (diameter<100 nm) from  both soluble compounds and from  larger particles of 
the same nominal elemental composition. This is an exciting capability that can facilitate 
epidemiological and toxicological research with natural and manufactured  nanomaterials. 
Methods 
Tissue Preparation 
Figure 2.1 outlines the tissue preparation, particle addition and isolation, and particle 
isolation. Tissue was prepared by collection of  whole lungs and livers post-mortem from 
male Sprague-Dawley rats, in accordance with an IACUC (Institutional Animal Care and 
Use Committee)-approved protocol. Tissues were snap frozen  in liquid nitrogen. The tissues 
were then ground with a mortar and pestle in liquid nitrogen. The powdered tissue was 
suspended in 3 ml per gram of  tissue of  a low-salt buffer  (20 mM HEPES, pH 7.9, 25% 
glycerol, 1.5 mM MgCl2, 0.02 M KC1, 0.2 mM EDTA, 0.2 mM phenylmethylsulfonyl 
fluoride,  and 0.5 mM dithiolthreitol). The tissue was processed by homogenization using a 
PR0200 series portable homogenizer (ISC BioExpress, Kaysville, UT) at 30,000 rpm until 
there were no visible chunks and then transferred  to a motor-driven Teflon-glass 
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N2(lq), pulverize 
grind and homogenize 
Tissue processing 
2.5 mg 70 nm Si02 
1.25 mg 250 nm Si02 
Incubate 1 hr at RT 
Collagenase 
Hyaluronidase — 
Incubate @ 37 °C for  24 hrs 
SDS 
Proteinase K 
-*• Tissue digestion #1 
Tissue digestion #2 
Incubate @ 65 °C for  2 hrs 
Tissue/Particle separation #1 Supernatant: 
Layer sample over saturated sucrose cushion • Low density hydrophilic 
and spin 25 min @ 21000 x g organics 
Phenol Wash Tissue/Particle separation #2 
Spin 25 min @ 21000 xg 
Lipids, nucleic acids and 
other organics 
Ethanol • Tissue/Particle separation #3 
Spin25min@ 21000xg 
Residual phenol 
Final sample • SdFFF 
Figure 2.1 Schematic of  the tissue sample preparation protocol. Adapted from  Deering et 
al. 2008 [94], 
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homogenizer (Potter-Elvehjem), (Fisher Scientific)  and run at 900 rpm for  2 full  passes to 
ensure the tissue was thoroughly homogenized. 
Nanoparticle Addition 
Aliquots of  particle suspensions in aqueous surfactant  (typically 1-2.5 mg) were 
added to homogenized lung or liver tissue. The addition of  particles to homogenized tissue 
demonstrated nanoparticle detection in a complex mixture of  biological material without the 
complications related to in vivo particle distribution, uptake and elimination. Particles were 
70 nm diameter SiC>2 (Z-PS-SIL-004-0,07, Postnova Analytics Landsberg, Germany) and 
250 nm Si02 (Alfa  Aesar, Ward Hill, MA). 
Enzyme Digestion 
Collagenase (150 U/ml) and hyaluronidase (100 U/ml) (Sigma Aldrich) were added 
to the homogenized tissue to break up the extracellular matrix. The mixture was incubated 
overnight at 37°C with shaking. The particle-spiked tissue was then sonicated using an 
Ultrasonic Processor (Cole-Parmer, Vernon Hills, Illinois) for  20 seconds (2 second bursts). 
To hydrolyze proteins, the tissue was incubated with 200 pg/ml Proteinase K (Sigma 
Aldrich) in 0.5% SDS for  2 hours at 65 °C. 
Acid Digestion 
A freshly  processed lung or liver tissue sample was transferred  to a glass test tube and 
an equal volume of  60% nitric acid (Fisher Scientific)  was added. The test tube was placed 
in a beaker of  hot (94°C) water for  about 1 hour or until the tissue was completely digested. 
The samples were then centrifuged  and the pellet washed with dilute acid and finally 
resuspended in 0.1% of  the aqueous surfactant  FL-70 (Fisher Scientific). 
Particle Isolation 
The tissue samples were layered over a saturated sucrose cushion and centrifiiged  at 
21,000 x g for  20 minutes in a microcentrifuge  (Eppendorf  North America, Westbury, NY). 
The pellets were resuspended in 0.1% FL-70 and sonicated for  20 sec (2 sec bursts). Phenol 
was added in a 1:1 (v/v) ratio and incubated with shaking for  5 minutes followed  by another 
round of  centrifugation.  The pellet was resuspended and washed with 70% ethanol and 
centrifuged.  The final  pellet was resuspended 500 pi and sonicated in 0.1% FL-70 with 
0.01% sodium azide (Sigma Aldrich, St. Louis, MO). 
SdFFF 
Analysis of  the final  samples was performed  by our collaborators and Postnova 
analytics using a Postnova SI01 particle fractionator  (Postnova Analytics, Salt Lake City, 
UT). The injected sample volume was 100 pi using 0.1% FL-70 as the carrier fluid  at a rate 
of  2 ml/minute. The initial speed of  centrifugation  was 1800 rpm and the final  speed was 
200 rpm. SdFFF run time was typically 90 minutes. Detection was achieved with a light 
scattering detector (Brookhaven, Holtsville, NY) at a 90° angle (690 nm laser). Takjiki et al. 
provides further  details of  the SdFFF methodology [49], 
Cell Culture 
Human aortic endothelial cells (HAEC, Cambrex, Bio Science Walkersville) were 
cultured in endothelial cell growth medium-2 (EGM-2, Cambrex, Bio Science Walkersville) 
at 37 °C, 5% C0 2 in a T-25 culture flask  (Corning, Corning, NY) or a glass bottom culture 
dish (MatTek Cultureware, Ashland, MA) until 90% confluent.  Cells were treated by 
replacing the medium with 4 ml of  fresh  EGM-2 containing 25 pg/cm2 rhodamine-labeled 70 
31 
nm Si02 (Z-PS-SIL-RFP-0,07 Postnova Analytics Landsberg, Germany) and incubated for 
24 hours. To harvest the cells and attached or internalized particles for  experiments, the 
culture medium was removed and the cells were washed with phosphate buffer  saline (PBS). 
Following the removal of  PBS, 1ml TrypLE enzyme (Invitrogen) was added according to the 
manufacturers  recommendations. The cells were washed from  the dish with fresh  media, 
collected by centrifugation  at 200 g, resuspended in 500 pi 0.1% FL-70 (Fisher Scientific) 
and sonicated with a probe for  20 seconds (2 second bursts). The particles and lysed cell 
content were then visualized via fluorescence  microscopy and processed by enzyme 
digestion starting with the Proteinase K step (Figure 2.1). 
Confocal  Microscopy 
HAECs were plated at 10,000 cells/cm2 and grown on a glass bottom culture dish till 
80% confluent.  The cells were treated with rhodamine-labelled 100 nm Si02 particles (Z-PS-
SIL-RFP-0,10; Postnova Analytics Landsberg, Germany) for  24 hours. The cell membrane 
was stained with wheat germ agglutinin (WGA) (green) and fixed  with ice cold 100% 
methanol. The treated and stained cells were visualized using an FV300-xy Olympus 1X70 
confocal  microscope (University of  Utah School of  Medicine Department of  Core Facilities) 
60x NA 1.45 oil emersion lens. Images were analyzed using Volocity software  (Perkin-
Elmer Applied Biosystems, Warrington, UK). 
Fluorescence Microscopy 
HAECs were plated at 10,000 cells/cm2 and grown on a glass bottom culture dish till 
80% confluent.  The cells were treated with rhodamine-labeled 70 nm Si02 particles (Z-PS-
SIL-RFP-0,07; Postnova Analytics Landsberg, Germany) and fixed  with ice cold 100% 
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methanol. The nuclei were stained with DAPI (Molecular Probes, Eugene, OR). The stained 
cells were visualized using an Olympus 1X50 fluorescent  microscope and a Hamamatsu 
camera. Images were analyzed using ImageJ software. 
Transmission Electron Microscopy 
Particle samples for  TEM were prepared by washing the particles, concentrating them 
by centrifugation,  and resuspending them in high-purity water or by direct collection of  the 
particles from  the SdFFF instrument. A 5 pL aliquot was placed on a formvar-coated  copper 
grid and allowed to dry overnight. Samples were imaged on a Philips Techni G2 electron 
microscope at 100 kV. 
Results 
The interaction between Si02 nanoparticles and HAECs was evaluated (Figure 2.2). 
HAECs were treated with 100-nm rhodamine-labeled Si02 particles for  24 hours to permit 
sufficient  interaction between the cells and the particles. To determine the localization of  the 
particles to the cells, WGA was used to stain the plasma membrane. A clear outline of  the 
plasma membrane was not seen due to rapid cycling of  the membrane as shown by the 
control cells stained with WGA in Figure 2.2A. Vesicle formation  due to the cycling of  the 
membrane permit visualization of  particles colocalized to these vesicles. Figure 2.2C is a z-
slice of  the circled area in Figure 2.2B. The yellow color observed in this slice demonstrates 
colocalization of  the red particles and the green stained vesicle. Since a primary cell line was 
used, transfection  of  a membrane GFP-fusion  protein which localizes to the cellular 
membrane could not be used. With the limitations of  fluorescent  microscopy, SdFFF was 
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Figure 2.2 Uptake of  100-nm Si02 into HAECs. A, Confocal  microscopy image of 
untreated control HAECs stained with WGA. B. Confocal  microscopy image of  HAECs 
treated with 100-nm rhodamine labeled Si02 particles (10 pg/cm2) for  24 hours. C. Z-slice 
of  the circled area in Figure 2.2a showing colocalization of  the particles and the WGA. 60X 




used in combination with microscopy to determine uptake of  inorganic metal oxide 
nanoparticles. 
Preliminary experiments were conducted to calibrate the instrumentation used in this 
study, and to determine the amount of  particles needed for  reliable detection. Dilutions 
prepared from  purchased Si02 standards (Postnova Analytics) with a known particle size, 70 
nm, and a starting concentration of  25 mg/ml of  particles suspended in aqueous surfactant 
were used. With the available light scattering detector, reliable quantification  of  the standard 
could be obtained with as few  as 7 x 1010 particles per injected sample, which is equivalent to 
25 pg of  particle mass as shown in Figure 2.3. Based on these data, our subsequent 
experimental work used tissue samples containing 1-2 mg of  particles. Using particle 
aliquots greater than 40 times the limit of  detection permitted robust quantification  in the 
experiments that were used to develop nanoparticle recovery protocols. 
To compare the SdFFF results to established techniques, fluorescence  microscopy 
and TEM was performed  on cell culture samples incubated with rhodamine-labeled Si02 
particles for  24 hours, rinsed to remove free  floating  particle and then prepared by enzyme 
digestion for  FFF analysis. Figure 2.4A shows a TEM image of  the starting 70-nm 
rhodamine-labeled particles in aqueous surfactant,  confirming  the manufacturer's  size. 
Figure 2.4B demonstrates the interaction of  70-nm rhodamine-labeled particles with HAECs. 
This image shows localization of  the nanoparticles to the cells and formation  of  micron sized 
aggregates which are visible by light microscopy. During the first  step of  our SdFFF particle 
analysis procedure, the cells were collected, lysed and treated with Proteinase K to digest 
proteins. Figure 2.4C shows a microscopy image of  the cell debris and aggregated 
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Figure 2.3 Fractograms of  70-nm SiC>2 particles injected at different  concentrations. 
Number of  particles in each fractogram  is shown next to the pointing arrows. The insert 
shows the calibration curve obtained using the particle number versus fractogram  peak area. 
Adapted with permission from  Takjiki et al. 2008 [49]. 
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Figure 2.4 Tracking the particles through the isolation procedure. A. TEM image of  the 
stock 70-nm rhodamine-labeled Si02 particles. B. Fluorescence microscopy image of 
HAECs treated with 70-nm-rhodamine labeled Si02 particles (10 pg/cm") for  24 hours. 20X 
objective 200X magnification.  C. Fluorescent image of  cell lysate containing particles. 20X 
objective 200X magnification.  D. TEM image of  a dried aliquot of  the final  sample after 
cleanup for  SdFFF containing 70-nm rhodamine-labeled SiOi particles in dried residual 
material. Reproduced with permission from  Deering et al. 2008 [94], 
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cleanup prior to FFF analysis was analyzed via fluorescence  microscopy to demonstrate the 
power of  the cleanup procedure. However, the particles were well dispersed, and not visible 
by light microscopy (data not shown). Figure 2.4D shows a TEM image of  these particles 
dried onto a grid. The particles are aggregated and coated by residual organic material. 
SdFFF separation of  the particles from  the soluble components yields the monodispersed 
particles that can be seen by TEM (Figure 2.5). These rhodamine-labeled Si02 particles have 
the same manufacturer,  nominal size, and surface  fractionalization  as the unlabeled Si02 
particles used for  the SdFFF experiments. 
Figure 2.6 shows a fractogram  demonstrating that unlabeled 70-nm particles could be 
recovered from  acid-digested human lung cells and rat lung tissue, sized by SdFFF, and 
quantified  with a light scattering detector. The elution time (proportional to size) of  the 
particles in the acid-digested sample agreed with the 70-nm standard in surfactant.  A "void 
peak" is commonly seen at the start of  an FFF separation [48]. Caldwell et al. describe this 
commonly seen peak as containing soluble components as well as suspended particles small 
enough to remain uniformly  distributed across the channel, even in the presence of  the field 
[43], Since the nitric acid process is limited to acid-insoluble particles, a more gentle tissue 
processing protocol utilizing protease enzymes was used. Lung tissue was used because it is 
the primary target in particle inhalation studies. Tissue processing method development 
experiments (data not shown) led to the protocol described in Methods section, which used 
specific  enzymes to digest the extracellular matrix, included an aqueous surfactant  in all 
processing steps, and used sonication to redisperse the particles after  centrifugation. 
To demonstrate the capability to distinguish nano-sized (diameter < 100 nm) and 
submicron particles alone and in lung tissue, mixtures of  two different  sizes of  Si02 particles 
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Figure 2.5 SdFFF fractogram  of  70-nm SiC>2 nanoparticles extracted from  lung cells. The 
inserted picture is a TEM micrograph of  the fraction  collected from  the peak maximum. 
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Figure 2.6 Bimodal distribution of  70 and 250-nm particles. A. SdFFF fractogram  of  the 
reference  sample of  70 and 250-nm particles mixed in surfactant.  The secondary x-axis 
depicts the theoretical particle size corresponding to the elution time for  two particle 
densities. B. SdFFF fractogram  of  70 and 250 nm particles isolated from  homogenized rat 
lung tissue. The inset graph is the circled area enlarged, emphasizing the 70 nm particle 
peak. Reproduced with permission from  Deering et al. 2008 [94], 
were added either to aqueous surfactant  (reference  sample) or to homogenized lung tissue, 
which was processed by the tissue digestion procedure. Figure 2.6A shows light scattering 
versus time from  FFF analysis of  the reference  sample normalized to the largest peak. This 
sample contains the 70- and 250-nm manufactured  Si02 particles at a 2:1 mass ratio in 
aqueous surfactant.  Figure 2.6B shows the enzyme-digested rat lung tissue containing 70-
and 250-nm manufactured  Si02 particles at the same concentration as in the reference  sample 
(2:1 ratio). The inset graph is a magnified  version of  the circled area showing that two 
particle sizes were clearly detected in a tissue sample. The graphs in Figure 2.6A and 2.6B 
show the expected bimodal distribution of  Si02 particles. The difference  in the relative sizes 
of  the 70- and 250-nm peaks in the reference  samples is due to the size-dependent sensitivity 
of  the light scattering detector. Rayleigh scattering theory predicts that scattering intensity 
from  a single particle varies with dp 6 where dp is particle geometric diameter. However, the 
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number of  particles for  a given mass increases inversely with dp , and the mass ratio of  the 70 
to 250 nm particles was 2:1. Thus, the expected ratio of  peak areas would be about 23:1. A 
similar experiment using a mixture of  80-nm and 500-nm particles in enzyme-digested rat 
lung tissue also produced the expected bimodal fractogram  (data not shown). The 
geometrical size of  the 70-nm particles was confirmed  by TEM of  a sample collected after 
the FFF separation (Figure 2.5). 
Well established FFF theory [41] permits the particle size corresponding to a given 
elution time to be calculated directly from  first  principles [49]. The calculation is based on 
measurable physical parameters of  the apparatus, the carrier fluid,  and the particle density, 
and involves the equations for  settling velocity, particle diffusion  rate, and laminar flow 
profile.  Figure 2.6 shows the theoretical particle sizes (top x-axis labels), corresponding to 
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the measured elution time (bottom x-axis labels), for  two different  particle densities. These 
assumed densities, 2.65 and 2.0 g/cm3, correspond to quartz and the density of  the 70-nm 
particles obtained from  the vendor datasheet. These densities span a reasonable range for 
various amorphous and crystalline forms  of  Si02. As can be seen from  the differences 
between the two sets of  theoretical sizes, the particle size corresponding to a given elution 
time does not change dramatically with moderate differences  in density. Thus, nanoparticles 
can be distinguished from  micron-sized particles even when the particle composition and 
density are uncertain. 
Particle recovery for  the experiment in Figure 2.6A and 2.6B can be estimated from 
the integrated area under the curve for  the SdFFF analysis of  the tissue sample and the 
reference  sample. Particle recovery in the enzyme digestion rat tissue processing was 30% 
for  the 250 nm particles and 22% for  the 70 nm particles. These recoveries are representative 
of  one set of  experimental data. 
Discussion 
The goal of  this study was to develop a technique that compliments existing 
methodologies and to provide detailed information  on the size distribution of  unlabeled 
submicron and nano-sized inorganic particles in toxicology samples. Elemental analysis and 
radioactive-labeled particles provide mass concentration data but not size data. Microscopy-
based techniques, as shown in Figures 2.2, 2.4 and 2.5, provide size data only after  image 
analysis of  a sufficient  sample to get accurate statistics and intracellular localization if 
membrane dyes are available for  the cell type. Manual image analysis is labor intensive and 
automated image analysis is subject to artifacts  from  overlapping particles or poor contrast 
from  the background. SdFFF complements the available techniques by providing detailed 
size without requirements for  particle labels. 
A wide range of  unlabeled submicron and nano-sized particles of  inorganic materials 
can potentially be detected in tissue samples by this methodology. All these proof-of-
concept experiments used Si02 particles, but the technique is directly applicable to a much 
wider range of  particle types, sizes, and shapes. The requirements for  particle detection by 
this technique are as follows:  the particle must be sufficiently  dense compared to the carrier 
fluid;  the particle must have a different  index of  refraction  from  the carrier fluid;  and the 
particle must be resistant to the reagents used for  tissue digestion and sample cleanup. These 
requirements are met by essentially all inorganic oxides, pure metal, and elemental carbon-
based particle types. Nonspherical particles can also be separated using SdFFF, but 
mathematical prediction of  retention time is more complicated than for  spheres. A study 
using rod-shaped aggregates of  latex particles showed that the SdFFF separation time is 
determined by the maximum dimension of  the particle rather than by an average size [95], 
Thus, this robust methodology is suitable for  use in a wide range of  particle toxicology 
studies that involve correlating biological effects  with the concentration of  nanoparticles in 
target organs. The particle size distribution information  furnished  by SdFFF separation will 
be uniquely applicable to comparisons of  the biological effects  of  solid particles versus the 
effects  of  soluble species, a question that cannot be answered by elemental analysis of  ashed 
or acid-digested samples. 
The important question of  quantifying  human lung burden of  combustion-generated 
nanoparticles provides an example of  how the sample preparation and SdFFF separation 
techniques can be used to complement other methods. Vehicle tailpipe emissions contain 
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submicron particles of  carbonaceous material from  incomplete combustion and metal oxides 
from  fuel  and lubricant additives and engine wear. The carbonaceous primary particulate 
includes both low-volatility compounds, referred  to as organic carbon, and essentially non-
volatile large polycyclic molecules, referred  to as elemental carbon or black carbon. Grigg et 
al. conducted a study that used light microscopy to measure black material in lung 
macrophages of  healthy children and correlated this lung burden with lung function  and 
modeled levels of  particulate matter [96], The light microscopy measured the two-
dimensional projected area of  particle aggregates. This approach is labor intensive, 
introduces artifacts  from  the image analysis, and provides no information  on the primary 
particle size distribution or the composition of  the opaque material. Saxena et al. recently 
published a technique for  quantitative estimation of  diesel and carbon black particles in lung 
cells based on adapting the thermal-optical-transmittance analytical technique developed for 
measuring organic and elemental carbon in air pollution samples [97]. This technique 
provides quantification  of  the low-volatility and nonvolatile carbon by a precise instrumental 
analysis method, but again provides no information  on the primary particle size distribution 
or on the metal oxide components. In contrast, SdFFF analysis of  tissue provides 
quantitative information  on the particle size distribution after  dispersal of  the recovered 
particles by sonication in surfactant.  The tissue processing method described in this chapter 
has the potential of  offering  high sensitivity since the centrifugation  steps concentrate the 
particles from  large volume of  digested tissue into a small aliquot for  analysis. Sequential 
collection of  samples during a SdFFF run is a well established technique [48]. The collected 
samples, which represent concentrated and size-segregated fractions  of  the initial particles, 
can be further  analyzed by transmission electron microscopy or elemental analysis. 
Compared to the other approaches cited above, the tissue digestion and SdFFF approach 
presented here provides the ability to analyze particle size distribution in large samples, such 
as a whole lung, and provides information  on both carbonaceous and metal oxide particles. 
Carbonaceous combustion particles have lower density than the silicon dioxide used in this 
study, but analysis of  carbon black by SdFFF has been demonstrated [98, 99]. . With 
additional method development, this technique can become a useful  tool to study 
environmental particle burdens in lungs. Little is known about the background level of 
naturally formed  nanoparticles, and this technique can also be applied to ecosystem studies of 
sentinel and food  chain organisms. 
Considerable future  research will be needed to fully  realize the potential of  this 
technique for  nanoparticle characterization in toxicology studies. Specifically,  improvements 
are needed to reduce particle losses during the enzyme digestion and particle recovery steps 
of  the tissue processing, to make the method sufficiently  reproducible, and to permit precise 
quantification  of  the nanoparticle burden per weight of  original tissue. This chapter describes 
experiments done with relatively high concentrations of  the particles because the goal was to 
demonstrate proof-of-concept.  The limit of  detection for  70 nm SiC>2 particles was 25 pg of 
particles per SdFFF analysis sample using a light scattering detector. This particle 
concentration in tissue is within the range reported by in vitro and in vivo nanoparticle 
toxicity studies. For example, a study of  fine  and nanoscale quartz particles reported 
statistically significant  responses with an intratracheal instillation dose of  1 mg/kg which 
equated to an initial burden of  about 140 pg of  particles per lung [100]. In an inhalation 
study exposing mice, rats, and hamsters to ultrafine  Ti02, the particle burden in the lung was 
1.6 mg Ti02/g of  tissue immediately post exposure [101]. Thus, the currently demonstrated 
enzyme digestion and FFF detection methodology is applicable to nanoparticle toxicology 
studies that use superphysiological doses. However, improvement in the method sensitivity 
will be needed for  use in toxicology studies that use environmentally relevant levels of 
exposures to particulates. The tissue processing protocol involves particle recovery by 
centrifugation  and the centrifugation  process intrinsically allows a sample to be concentrated. 
Processing larger initial tissue samples and recovering the particles in a small final  volume is 
a straightforward  way to achieve detection of  low particle concentrations in tissue. 
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CHAPTER 3 
DIFFERENT VASCULAR AND PULMONARY CELL ADVERSE CYTOKINE 
RESPONSES TO METAL OXIDE NANOPARTICLES 
Introduction 
In Chapter 1, the interaction between HAECs grown in a culture flask  and 70-nm 
Si02 at a dose of  10 pg/cm2 was shown with fluorescence  microscopy. At this dose, the 
particles were clearly interacting with the cells, which appeared intact and alive. This 
chapter focuses  on the effects  of  metal oxide particles, including silica, on various cell types. 
Similar studies have been done by Veranth et al., but the focus  was on human bronchial 
epithelial cells (BEAS-2B) treated with a large matrix of  particles [102]. Common endpoints 
included cytotoxicity and cytokine production and release. 
Investigation of  the cytokine inducing effects  of  particles has been a staple for 
determining safety  of  particles in biological systems. For example, CRP, an acute phase 
protein clinically used to determine cardiovascular risk, is an indicator of  infection,  injury 
and inflammation  [103, 104]. CRP detected in the blood is produced from  hepatocytes under 
the transcriptional regulation of  IL-6. The increased production and release of  IL-6 in any 
tissue may spill over into systemic circulation, interacting with vascular endothelial cells, 
leading to activation of  transcription factors  that change gene regulation [105]. Particle-
induced tissue inflammation  may damage the cells at the surface  of  the tissue, resulting in the 
loss of  integrity of  the tissue's defenses  [106], 
The goal of  the chapter is to show that vascular cells are more sensitive to metal oxide 
nanoparticles than pulmonary cells, causing enhanced cell death and release of  cytokines. 
Direct comparisons between already published research are difficult  because of  experimental 
variables. Experimental techniques, cell lines, and particle variability (from  manufacturer  to 
manufacturer  and from  lot to lot), vary among multiple laboratories. Results presented here 
overcome these experimental variables by using a single source of  particles for  the treatment 
and comparing the responses in vascular, pulmonary and colon cell lines directly. 
Methods 
Cell Culture 
Table 3.1 describes the cells used in this study. Human umbilical vein endothelial 
cells (HUVECs) and HAECs were purchased from  Cambrex (Cambrex Bio Science 
Walkersville, MD) and cultured in endothelial growth medium-2 (Clonetics/Lonza, 
Walkersville, MD) using passages 4-9, as per manufacturers'  recommendations. BEAS-2B 
cells (CRL-9609) were purchased from  American Type Culture Collection (ATCC; 
Rockville, MD) and cultured in serum-free  LHC-9 media, prepared by fortifying  Lechner and 
LaVeck LHC-8 media (BioSource, Camarillo, CA) with retinoic acid (33 nM) and 
epinephrine (2.75 pM). Normal human bronchial epithelial (NHBE) cells, a primary 
bronchial epithelial cell line, were purchased from  ATCC and cultured in serum-free 
bronchial epithelial growth media (Clonetics/Lonza, Walkersville, MD), using passages 4-9. 
Culture flasks  (Corning, Corning, NY) for  the NHBE cells were precoated at 37°C with 
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Table 3.1 Cell types used in this study. 
Origin Abbreviation Definition 
Vascular HUVEC* 
HAEC* 
Human Umbilical Vein Endothelial Cells 
Human Aortic Endothelial Cells 
Pulmonary BEAS-2B 
NHBE* 
SV40 Transformed  Human Bronchial Epithelial 
Normal Human Bronchial Epithelial Cells 
Colon RKO 
CaCo2 
Human Colorectal Cancer Cell 
Human Colonic Carcinoma Cell 
* Primary cell lines 
LHC-basal medium (BioSource, Camarillo, CA) fortified  with collagen (30 pg/ml), 
fibronectin  (10 fag/ml),  and BSA (10 pg/ml) (Invitrogen, Carlsbad, CA). Caco-2 and RKO, 
colon cancer cells, were purchased from  American Type Culture Collection (ATCC, 
Rockville, MD) and cultured in Advanced Dulbecco's Modified  Eagle Medium (DMEM) 
supplemented with 2% FBS and Glutamax (Invitrogen, Carlsbad, CA). All cells were 
maintained at 37°C in an air-ventilated and humidified  incubator with 5% carbon dioxide. 
For subculturing, cells were trypsin-dissociated and passaged every 2-4 days. 
Particle Treatment 
The particles used in this study are described in Table 3.2. Particles were sterilized 
with 70% ethanol and dried at 80°C to avoid biological contamination of  the cell culture 
media. Each experiment included an untreated control. Results were replicated using 
additional independent passages of  cells. To limit experimental variability, stock solutions of 
all materials were made for  subsequent experiments. Before  treatment of  cells, the particles 
were dispersed by sonication for  5 minutes in an ultrasonic bath, and vortexed immediately 
before  use. 
Cell Viability - Dojindo CCK-8 Assay 
To measure cell viability, cells were subcultured in 96 or 48-well plates, grown until 
the cells reached 80% confluence,  and incubated with particles for  24 hours. Cytotoxicity of 
the metal oxide nanoparticles was measured using the Cell Counting Kit -8 assay (Cell 
Counting Kit CCK-8, Dojindo Laboratories, Gaithersberg MD). This assay measures 
metabolic activity by mitochondrial reduction of  the reagent to form  a colored product, and 
results were adjusted by subtracting the response of  the blanks, and reported as fold  over 
Table 3.2 Metal oxide particles used in this study. 
Particle Defined 
Full Name Formula Nano Micron 
Cerium IV Oxide Ce02 9-15 n m
a a 
5 pm 
Iron (III) Oxide Fe203 i a 
3 nm 
c a 5 pm 
Silicon Dioxide Si02 10 nm
b 0.5-10 pmc 
Titanium Dioxide Ti02 c b 5 nm 
1-2 pma 
Zinc Oxide ZnO 8-10 nma 44 pma 
aAlfa  Aesar 
^anoStructure and Amorphous Materials INC 
0 Sigma Aldrich 
51 
untreated control. Immediately after  harvesting the media for  cytokine analysis, WST-8 
reagent was mixed with cell culture media (4%), added to the cells and incubated for  2 hours 
before  reading absorbance. Data were quantified  the absorbance ratio (>.=450/630). 
Enzyme-Linked Immunosorbent Assay (ELISA) 
To measure the cytokine release, cells were plated in 48-well plates, grown until the 
cells reached 80% confluence,  and treated with particles. The media was harvested from  the 
wells 24 hours after  particle treatment. The concentration of  interleukin-6 (IL-6) in the cell 
culture media was determined using a sandwich ELISA assay. For IL-6, 96-well Nunc 
MaxiSorp immuno plates (Fisher Scientific)  were coated with anti-human IL-6 (eBioscience; 
San Diego CA) overnight at RT followed  by exposure to the cell culture media. Biotin-
conjugated anti-human IL-6 (eBioscience; San Diego CA) was then added to the reaction and 
detected using avidin horseradish peroxidase (eBioscience, San Diego CA). Absorbance was 
read on a Molecular Devices Model SpectraMax 250 plate reader with Softmax  Pro software. 
The concentration of  IL-6 was determined based on a standard curve, consisting of 
recombinant human IL-6 standard (R&D systems, Minneapolis, MN) run on each plate. 
Real-Time PCR 
An overview of  the real-time PCR methodology is described in Figure 3.1. Cells 
were plated at a density of  10,000 cells/cm2 and grown in a 6-well plate until 80% confluent 
and then treated with particles. An additional 100 nm Si02 particle (Z-PS-SIL-RFP-0,1; 
Postnova Analytics Landsberg, Germany) was used in this study. After  24 hours, unless 
otherwise specified,  total RNA was extracted from  treated cells using the RNeasy total RNA 
isolation kit (Qiagen, Chatsworth, CA). One microgram of  total RNA was reverse-
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Figure 3.1 Schematic diagram of  real-time PCR process. un 
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transcribed to cDNA using random hexamer primers and a cDNA synthesis kit containing 
Superscript II RT enzyme (Invitrogen, Carlsbad, CA). The resulting cDNA was then diluted 
1:50 and 2.5 pi used for  each real-time PCR reaction. IL-6, IL-8, and 18s rRNA genes were 
amplified  using the following  primers: 18s rRNA: Sense- 5'- TGGTTGCAA AGC TGA 
AAC TTA AAG -3' and anti-sense- 5'- ACT CAA ATT AAG CCG CAG GC -3', IL-6: 
Sense- 5' AAC CTG AAC CTT CCA AAG ATG G -3' and anti-sense- 5'- TCT GGC TTG 
TTC CTC ACT ACT -3', IL-8: Sense- 5'- ACT GAG AGT GAT TGA GAG TGG AC -3' 
and anti-sense 5'- AAC CCT CTG CAC CCA CTT TTC -3'. The real-time PCR reaction 
was carried out using 4 pM primer, diluted template and LightCycler" 480 SYBR Green I 
Master Mix (Roche, Indianapolis, IN) using the manufacturers  recommendations. The 
reaction was run on a Lightcycler" 480 system (Roche, Indianapolis, IN). Standard curves 
were prepared for  each gene. IL-6 (Image: 3884652) and IL-8 (Image: 3882471) image 
clones were purchased from  ATCC. (ATCC, Rockville, MD). 18s rRNA was cloned into 
TOPO 2.1 vector as per manufacturers  recommendations (Invitrogen, Carlsbad, CA). The 
data was analyzed using Lightcycler 480 software  (Roche, Indianapolis, IN). The results 
are reported as fold  over control after  normalization to the housekeeping gene. 
Statistical Analysis 
The dose at which 50% of  cells are dead (LD50) values were obtained by nonlinear 
regression analysis using the sigmoidal dose-response (variable slope) equation (Prism 4, 
GraphPad Software  Inc, San Diego, CA). Statistical analysis was performed  using either a 
One- way ANOVA with a Dunnett's post hoc test or a student's t-test (p <0.05). 
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Results 
Cytotoxicity of  metal oxide particles 
Cytotoxicity was measured by incubating the cells listed in Table 3.1 with metal 
oxide particles. After  a 24 hour incubation, cytotoxicity was assayed by the reduction of  the 
CCK-8 reagent which measures metabolic activity of  the mitochondria. Figure 3.2 shows the 
dose response graphs of  HAECs treated with the metal oxide nanoparticles listed in Table 
3.2. The bars illustrate fold  over control responses, and control values are untreated cells. 
The dose range is 1.0 to 316 pg/cm2, common doses used among particle toxicologists in cell 
culture to elicit cellular responses. Figure 3.2A shows a dose response to 10-nm SiC>2 
particles. The lowest dose that produced a statistically significant  loss of  viability was 31.6 
pg/cm . The other metal oxide nanoparticles in Figure 3.2 show a similar dose response, but 
the exception was ZnO, which results in greater than 90% loss of  viability at doses higher 
than 10 pg/cm . 
To compare vascular cell responses to pulmonary epithelial cell responses to 
particles, BEAS-2B cells were treated with the same batch of  particles as shown in Figure 
3.3. The lowest dose that produced a statistically significant  loss of  cellular viability with 
BEAS-2B cells was 100 pg/cm2. Other nanoparticles did not elicit significant  cytotoxicity at 
the highest dose tested. ZnO caused complete cell death at concentrations higher than 3.16 
pg/cm . 
A full  comparison of  the LD50 of  metal oxide particles in various cell types is 
summarized in Table 3.3. Some of  the particles did not elicit cytotoxicities to multiple high 
concentrations, so LD50 values are simply estimated to be greater than 350 pg/cm . These 
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Figure 3.2 Cytotoxicity of  metal oxide nanoparticles in HAECs. Cells were treated with increasing doses of  A. 10 nm Si02 B. 5 nm 
Ti02 C. 9-15 nm Ce02 D. 3 nm Fe203 E. 8-10 nm ZnO. Data represent viability represented as fold  over untreated control. Each 
bar represents n=6. Statistically significant  decrease in cell viability relative to untreated controls (One-way ANOVA, Dunnett's post 










0.0-1 i p o o 
















o 0.4H u. 
0.2 
0.0- i o o 








0.0- I VO ® vo o — — 










i i i r 
O^ O VO O VO — — ^ o — 
r<1 
Dose 8-10 nm ZnO (pg/cm ) 
Figure 3.3 Cytotoxicity of  metal oxide nanoparticles to BEAS-2B cells. Cells were treated with increasing doses of  A. 10 nm Si02 
B. 5 nm Ti02 C. 9-15 nm Ce02 D. 3 nm Fe2C>3 E. 8-10 nm ZnO Bars show viability as fold  over untreated control. Each bar 
represents n=6. Statistically significant  decrease in cell viability relative to untreated controls (One-way ANOVA, Dunnett's post hoc 
test, p<0.05) are identified  with an asterisk (*). 
2 • • Table 3.3 LD50 (pg/cm ) of  metal oxide nanoparticles treated cells. 
NANO MICRON 
Ce02 Fe 2 0 3 SiOz Ti0 2 ZnO Ce0 2 Fe 2 0 3 Si0 2 Ti0 2 ZnO 
HUVEC 40 33 60 37 26 34 89 37 35 13 
HAEC 19 11 29 19 12 30 65 35 100 10 
BEAS-2B 153 53 >350 >350 8 >350 >350 >350 >350 8 
NHBE >350 >350 >350 146 4 30 >350 >350 >350 1 
RKO 143 >350 >350 >350 21 >350 >350 129 >350 21 
CaCo2 63 >350 >350 >350 30 >350 >350 >350 105 22 
demonstrate that the vascular cell lines treated with metal oxide particles have lower LD50 
values than the pulmonary and colon cell lines. Micron-sized particles were also tested to 
determine if  this overall sensitivity was selective for  nanoparticles. The LD50 values were 
generally higher with micron-sized particles, but the overall enhanced sensitivity of  vascular 
cells is still observed. 
Cytokine Response to Metal Oxide Nanoparticles 
To ensure that the enhanced sensitivity of  vascular cells applies to additional adverse 
effects,  cytokine responses to metal oxide nanoparticles were measured. An ELISA was 
used to measure IL-6 concentrations in the culture medium harvested from  cells after  a 24 
hour exposure to nanoparticles. The results of  HAECs treated with titanium, cerium and 
silica nanoparticles are shown in Figure 3.4. All of  the particles tested show positive dose-
response and reach statistical significance.  Statistically significant  IL-6 response was seen at 
doses as low as 0.1 pg/cm2 with Si02 (Data not shown) which is near a calculated 
physiologically relevant dose for  injected nanoparticles used for  drug delivery or imaging 
contrast agents [51]. 
NHBE cells, a primary bronchial epithelial cell line, shows no significant  increase in 
IL-6 release even at doses previously shown to be cytotoxic, Figure 3.5. IL-6 release, 
although not significantly  produced in these studies was shown to be induced by soluble 
vanadium during previous studies in the Veranth Lab at the University of  Utah. A 
comparison of  the cytokine inducing dose of  the metal oxide particle for  the different  cell 
types is shown in Table 3.4. Micron and nano-sized particles are shown, and again the most 
important difference  is observed between the cell types, not the particle sizes. The data in 
this table are a work in progress suggesting a pattern of  enhanced sensitivity of  the vascular 
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0.0 0 3 1.0 3.2 10.0 
Dose of  particle (fig/cm2) 
Figure 3.4 IL-6 protein release from  HAECs. Bars show IL-6 concentration represented as 
fold  over untreated control. Each bar represents at least n=3. Statistically significant 
changes in IL-6 relative to untreated controls (student's t-test, p<0.05) were not observed. 
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1.6-1 
Dose of  particle (fig/cm2) 
Figure 3.5 IL-6 protein release from  NHBEs. Bars show IL-6 concentration represented as 
fold  over untreated control. Each bar represents at least n=3. No statistically significant 
increases in IL-6 relative to untreated controls were observed. 
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Table 3.4 Concentration resulting in statistically significant  IL-6 production (pg/cm2) 
NANO MICRON 
Ce02 Si02 Ti02 ZnO Ce02 Si02 Ti02 ZnO 
HAEC 3 0.1 10 * 3 0.3 0.3 * 
NHBE >100 >100 >100 * no data 100 100 no data 
CaCo2 no data >100 >100 100 no data no data no data no data 
* significant  cell death a low concentrations 
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cells however further  experiments with a larger matrix of  cell types is needed. 
To confirm  the cytokine effects  of  metal oxide nanoparticles to HAECs, quantitative 
real-time PCR for  IL-6 and IL-8 message was performed.  An ELISA was performed  after  a 
24 hour treatment, measuring the accumulation of  IL-6 protein in the cell culture medium 
over time. For the measurement of  IL-6 and IL-8 mRNA induction, a time course was 
needed to determine the point at which induction was the greatest. Figure 3.6 graphically 
shows the time course results for  IL-6 and IL-8 and the peak gene induction for  both genes 
occurred at 12 hours or later. IL-8 gene induction appears to be higher in HAEC and 
HUVECs. The difference  between vascular cells depends on the gene. For IL-6 HAEC 
seem to have a higher response and the opposite is true for  IL-8. The gene induction for  both 
IL-6 and IL-8 persists to 24 hours (data not shown). A time course was not performed  for 
pulmonary cells considering the results of  the IL-6 ELISA showed no increase in cytokine 
production over 24 hours when treated with particles. Figure 3.7 shows a lack of  cytokine 
gene induction in NHBE cells at 24 hours at two doses. 
Discussion 
The goal of  this chapter was to show that vascular cells, represented as HAEC and 
HUVECs, are more sensitive to metal oxide nanoparticles than other cell types including 
pulmonary and colon cells. The primary focus  of  previous research has been on 
environmental and occupational exposures to particles. Two of  the most common routes of 
entry of  these particles are through inhalation and ingestion. Therefore,  pulmonary cells 
have been a primary focus  of  study. Recent publications have suggested that nanoparticles 
translocate into systemic circulation, allowing interaction with other tissues 
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Figure 3.6 Cytokine gene induction in vascular cells. A. IL-6 gene induction in HAEC and 
HUVECs treated at 2, 4, 8, and 12 hour time points with 100-nm Si02. B. IL-8 gene 
induction. The dose used was 10 pg/cm , a dose which does not cause significant 
cytotoxicity. Bars are copies of  IL-6 normalized to copies of  18s rRNA and then represented 
as fold  over untreated control. Each bar represents n=3. Statistically significant  changes in 
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Figure 3.7 The cytokines IL-6 and IL-8 gene induction in NHBEs. RNA was harvested at 
24 hours. The doses used were 10 and 31.6 pg/cm2, which does not cause significant 
cytotoxicity. Data represents copies of  IL-6 or IL-8 gene copies normalized to copies of  18s 
rRNA and then represented as fold  over untreated control. Each bar represents n=3. 
Statistically significant  changes in message relative to untreated controls (student's t-test, 
p<0.05) were not observed. 
to occur [24, 33-35, 40]. As mentioned in Chapter 2, many particles used to evaluate 
deposition typically have a specific  label, making them of  limited relevance to environmental 
and occupational exposures. Geiser et al. tracked unlabeled 22-nm Ti02 in the lung using 
energy-filtering  transmission electron microscopy, and found  particles on the luminal side of 
airways and alveoli as well as in all major lung tissue compartments, cells and in capillaries 
[22]. Thus, the relevance of  the effects  of  inhaled nanoparticles in the vasculature becomes 
apparent due to secondary vascular exposure. Beyond environmental and occupational 
exposures, nanoparticles are being used for  drug delivery, also validating the need for 
investigation into the effects  particles have on the vasculature. Slowing et al. provide a 
review of  mesoporous silica nanoparticles used for  controlled release drug delivery [107]. 
The importance of  the metal oxide particles used in this chapter was reviewed in 
Chapter 1. In this Chapter, effects  of  metal oxide particle on vascular versus pulmonary and 
colon cells was examined. A careful  comparison of  susceptibility of  multiple cell lines to 
nanoparticles has not been reported. Some studies have been done in various cell lines by 
different  research groups using an array of  particles. However, comparisons of  these 
experiments are difficult  because different  experimental conditions were used. Particle 
variability is a major confounding  variable not only from  manufacturer  to manufacturer,  but 
from  lot to lot from  the same company. Veranth et al. described the effects  of  culture 
medium, culture well size, percent confluence  and source of  cell types as major factors  in 
measurements of  cellular responses to particles, demonstrating the need for  a uniform 
experimental matrix as described in this chapter [108]. 
The data shown in this chapter indicate that vascular endothelial cells are more 
sensitive to metal oxide particles than pulmonary and colon cell lines. However, some 
cytotoxicity reports in vascular cells do not corroborate these results. Peters et al. treated 
microvascular endothelial cells with Ti02 and SiC>2, showing no loss in viability and a slight 
increase in IL-8 protein release [109]. This difference  or lack of  sensitivity is most likely due 
to the cell type differences,  since microvascular cells express different  proteins, are 
responsible for  different  cellular functions,  and are under different  stresses than HAECs and 
HUVECs. A study using ZnO and Fe203 was done in HAEC showing that these particles are 
cytotoxic and induce IL-8 message, with a maximum effect  at 4 hours [110]. These data 
agreed with our results for  zinc and iron oxide except the maximum induction we observed 
was at 12 hours. Fujii et al. treated primary human bronchial epithelial cells that they 
isolated from  donor lungs with PMio showing maximum IL-8 induction at 8 hours [62]. 
These results may disagree because of  the differences  between experimental techniques. The 
cells treated for  PCR in this chapter were done in a 6 well plate. The settling velocity of  the 
particle as described in Chapter 1 may alter the actual concentration at a specific  time point. 
Additional variables might include experiments with different  volumes, with particles of 
varying densities. The cells may have come from  a different  donor/vendor, altering the cells 
response to the particles. Additionally, as shown in precious studies, responses can be 
titrated by using different  culturing conditions [108]. Chang et al. suggest that Si02 toxicity 
is based on metabolic activity of  the cell type, and that cells with a longer proliferation  time 
are more sensitive to silica [111]. Further research will need to be done to determine the 
cause of  these differences. 
Gojova et al. also showed the same complete cell death with ZnO at doses of  50 
pg/ml which is roughly equivalent to our 31.6 pg/cm2 dose [110]. Follow up work by the 
same group showed that the effects  were not from  liberated metal ions [110]. These data 
were confirmed  by the Moos lab at the University of  Utah indicating it is the particles 
causing the observed affects.  The mechanism by which the particles elicit tfiis  effect  is still 
under investigation. Perhaps particles binding to surface  receptors is occurring or the 
particles are internalized, activating signaling cascades, leading to cell death. 
Incubations of  particles with colon cells, though relevant due to ingestion of 
nanoparticles, are rarely published. However, since the colon is constantly exposed to 
various contaminants from  food  and other ingested materials, and serves as a barrier to the 
rest of  the organs of  the body, it is not surprising that the particles used in this study did not 
cause significant  toxicities or inflammation.  Translocation of  nanoparticles may occur 
through the colon since it is a site of  nutritional absorption. The pulmonary cells may be 
subject to the same lack of  sensitivity. The lung is also exposed to a large variety of 
environmental pollutants and may have become desensitized to the toxic effects  of  particles. 
Unlike colon cells, with exposure to particles pulmonary cells have been extensively studied. 
Veranth et al., using the same particles, showed a lack of  cytotoxicity and minimal cytokine 
production in BEAS-2B cells [102], Other research by Steerenburg et al. show the same lack 
of  response to Ti02 particles in BEAS-2B cells but show a pronounced response to fumed 
silica, which we did not observe [112]. NHBE cells are potentially more important 
comparison to HAECs. Both of  these cell types are primary cultures, not immortalized or 
cancer derived. All NHBE data presented here indicate that these cells are not sensitive to 
the metal oxide nanoparticles, results similar to BEAS-2B cells. While the metal oxide 
particles tested here do not elicit a pronounced effect  in the pulmonary cells, some particle 
types are cytotoxic and induce a cytokine response. In A549 lung cells, Lin et al. showed 
that amorphous silica nanoparticles caused cell death greater than the well characterized 
crystalline silica [113]. This does not completely contradict the data shown in this chapter, 
since a significant  loss of  viability was shown in pulmonary cells treated with Si02. Fujii et 
al. show that human bronchial epithelial cells exposed to ambient air pollution particles, 
PMio, show significant  IL-8 induction [62], 
An interesting unexpected observation was the difference  between vascular cell lines. 
The LD50 values for  HUVECs are higher than for  HAECs. Furthermore, IL-6 and IL-8 gene 
induction (Figure 3.6) differs  between the cells as well. Both of  these cells are subcultured in 
the same medium in the same manner, the only difference  between them is their tissue origin 
and donor. HAECs are isolated from  the aorta and HUVEC are isolated from  the umbilical 
vein. Studies using isolated umbilical cords show that particles do not enter placental 
circulation [114] which is important because the umbilical cord serves as an important barrier 
protecting the growing fetus.  Differences  between aortic and venous cells may be important 
factor  influencing  the differences  in gene induction and cytotoxicity. The most notable 
difference  between veins and arteries is the blood they both carry. Arteries carry oxygenated 
blood from  the heart to tissues while veins carry deoxygenated blood, CO2 and other waist 
back to the heart. However, umbilical veins carry oxygenated blood to the growing fetus. 
Other difference  between these cells may be the variation of  genes expressed in the different 
cell types and their capability to produce and detoxify  ROS. Viability data from  HAECs is 
pooled from  multiple donors with minor variations between the two. Investigation into the 
mechanism by which particles induce cellular alterations in aortic versus venous cell lines as 
well as other vascular endothelial derived cells needs to be completed before  any conclusions 
can be made. 
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A popular hypothesis among particle toxicologists is that surface  area or the 
composition of  the particle determines the cellular effects.  The cytotoxicity results presented 
in Table 3.3 do not conclusively support this surface  area hypothesis. For instance, the 
difference  in LD50 for  SiC>2 in HAEC is no different  for  nano- (large surface  area) versus 
• • . 9 
micron-sized (smaller surface  area) particles, both LD50S were approximately 30 pg/cm . 
• • 2 2 However, in the same cell type, Ti02 varies from  19 pg/cm for  nano and 100 pg/cm for 
micron-sized particles. These results may support the theory that the composition of  the 
particle is responsible for  the cellular seen, as shown by all results with ZnO. These particles 
clearly kill all cells equally. As stated previously, free  zinc ions are not responsible for  cell 
responses. Each particle of  composed of  different  metal ions may interact with cells 
differently.  This interaction may be internalization or binding to surface  receptors. 
Future directions for  this research should focus  on the difference  in susceptibilities of 
the cell types. A gene array of  all three cell types treated with nanosilica may give insight 
into which genes are important in the various cell lines leading to their differential  responses. 
Additionally, studies should be done to determine the mechanism by which particles cause 
cytokine induction. Studies in the Veranth Lab were performed,  pretreating BEAS-2B cells 
with inhibitors of  cytokine receptors as well as inhibitors of  the MAP kinase pathway; 
however results IL-6 ELISA results were inconclusive. 
CHAPTER 4 
EVALUATE THE ROLE OF APOPTOSIS AND REACTIVE 
OXYGEN SPECIES IN ENHANCED SUSCEPTIBILITY 
OF VASCULAR CELLS 
Introduction 
In previous chapters, experiments have focused  on HAECs interaction with and 
sensitivity to silica particles. In this chapter, the mechanism of  this enhanced sensitivity will 
be investigated through examination of  apoptosis and the mechanisms leading to apoptosis. 
Knowledge regarding silica-induced cellular apoptosis is increasing daily, and the 
majority of  the studies focus  on crystalline silica or Min-U-Sil, typically 1 -5 pm particulates. 
The study of  micron-sized crystalline silica is important because of  occupational exposure to 
silica lead to a well characterized syndrome known as silicosis. The role of  silica-induced 
apoptosis in pulmonary cells after  exposure to micron-sized crystalline silica has been 
thoroughly studied [115-118]. Furthermore, micron-sized crystalline silica-induced 
apoptosis and ROS have been investigated in HAECs [119]. 
The goal of  this chapter is to show that vascular cells treated with 10-nm amorphous 
silica stain positive for  apoptosis that can be prevented by inhibiting the formation  of  ROS. 
To quantify  apoptosis, an Annexin V (AV) assay was used. This assay utilizes the 
externalization of  phosphatidylserine (PS), a cell membrane phospholipid, typically found  on 
the cytoplasmic side of  the cell membrane. PS is flipped  to the outer membrane of  the cell 
during apoptosis, serving as a signal for  recognition and degradation of  apoptotic cells by 
phagocytes. To detect apoptosis, FITC-conjugated AV binds to PS and the fluorescence  is 
measured by flow  cytometry. Gating of  fluorescent  cells permits the quantification  of  the 
cells undergoing apoptosis in a given population. Figure 4.1 depicts this process. Additional 
studies were performed  using this assay to assess the role of  ROS in silica-induced apoptosis. 
Methods 
Particles 
The particles used in this Chapter include 10-nm (Nanostructured & Amorphous 
Materials, Inc., Houston, TX) or 70-nm (Z-PS-SIL-004-0,07, Postnova Analytics Landsberg, 
Germany) Si02. 
Cell Culture 
The cell lines used in this chapter were previously described in Chapter 3. Refer  to 
Table 3.1 for  cell descriptions. HAECs, HUVECs, and BEAS-2B cells were grown in 6-well 
plates (BD Falcon; Fisher Scientific,  USA). HAECs and BEAS-2B cells were treated at 70% 
confluence  with 10-nm Si02 (Nanostructured & Amorphous Materials, Inc., Houston, TX). 
HUVECs were treated at 70% confluence  70-nm (Z-PS-SIL-004-0,07, Postnova Analytics 
Landsberg, Germany) Si02 as part of  a different  experimental matrix but the data are 
V. 
presented in this Chapter to confirm  HAEC data in a second vascular cell line. Camptothecin 
(Sigma Aldrich, St Louis, MO) was used as a positive control for  the induction of  apoptosis. 
To investigate the role of  ROS in cellular apoptosis, cells were pretreated with 5 mM N-
acetyl-L-cysteine (NAC) (Sigma Aldrich, St Louis, MO) before  treatment with particles. 
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Figure 4.1 Apoptosis - Annexin V-FITC diagram 
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Apoptosis Assay 
Apoptosis was measured using Vybrant® Apoptosis Assay Kit #3 (Molecular Probes, 
Eugene, OR). After  a 24 hour treatment, culture media was removed, cells were trypsin-
dissociated and added back to the previously removed culture medium. The cells were 
centrifuged  at 200 x g for  5 minutes. The pellet was washed two times with ice cold PBS. 
The final  pellet was resuspended in AV-binding buffer  provided in the kit. Samples were 
incubated for  15 minutes with propidium iodide (PI) and FITC-conjugated AV before 
analysis on a Cell Lab Quantum Flow Cytometer (Beckman Coulter, Fullerton, CA). 
Results 
Apoptosis in Multiple Cell Lines 
The flow  cytometry data obtained from  a control sample is represented in Figure 4.2. 
The two dyes used in this assay are PI and AV. PI is a cell impermeable nuclear dye used to 
determine cell viability by assessing membrane permeability. AV belongs to the family  of 
proteins known as the annexins. Annexins are anticoagulants but have been found  to 
2+ 
preferentially  bind to negatively charged phospholipids like PS in the presence of  Ca . 
Binding of  AV to PS permits the detection and quantification  of  apoptosis. The results are 
presented as a cell plot with four  quadrants. As indicated in Figure 4.2, the separate 
quadrants are as follows:  PI positive AV negative cells (Ql), PI and AV positive cells (Q2), 
AV positive PI negative cells (Q4) and PI and AV negative cells (Q3). When cells are 
stained positive for  both FITC and PI, this is indicative of  late apoptotic or necrotic cells 
since PS is externalized and PI is able to enter the cells. Since the cell population in this 
quadrant is not fully  characterized as either late apoptotic or necrotic it is not useful  for  the 
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Figure 4.2 Representative cell gating by flow  cytometry for  the untreated control. Cells 
stained with the different  dyes are represented in each quadrant as labeled. Q4 represents the 
percentage of  apoptotic cells and will be used for  the quantification  of  apoptosis. 
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measurement of  apoptosis. The quadrant that will be used for  the determination of  apoptosis 
is Q4. The only signal measured in this quadrant is from  AV-FITC binding, indicating that 
these cells are undergoing apoptosis, as measured by the externalization of 
phosphatidylserine. 
Figure 4.3 graphically represents the apoptosis assay data from  HAEC treated with 
increasing doses of  silica for  24 hours. Camptothecin, an anti-cancer drug, was used as a 
positive control to induce DNA damage. Camptothecin acts by stabilizing topoisomerase I, 
preventing re-ligation of  DNA, resulting in apoptosis. For almost all of  the treatments, the 
percentage of  cells in Q1 is negligible and the percent of  cells in late apoptosis/necrosis is 
relatively low with the exception of  cells treated with 31.6 pg/cm SiC>2. In Chapter 3, this 
dose was shown to be significantly  cytotoxic and these results confirm  this previous 
observation. Untreated cells are 60% viable with roughly 25% of  cells staining positive for 
AV. A basal level of  AV staining is typical for  most cell lines since there is a certain amount 
of  PS always present on the external surface  of  the cell membrane. All other treatments 
show increases of  FITC-stained cells over control with minor changes in FITC-PI staining. 
Figure 4.4 shows the percentage of  cells from  Q4 representing apoptosis. Our positive 
control has increased significantly  over untreated controls in both HAECs and HUVECs. 
Silica treatment also significantly  increases the percentage of  apoptotic cells, showing that 
our positive control and silica treatments induce apoptosis in vascular cells. 
Data from  previous chapters have shown a lack of  pulmonary cell response to silica 
until the upper limits of  doses tested. Figure 4.5 graphically represents the data from  FITC-
conjugated Annexin V stained BEAS-2B cells. Silica failed  to induce significant  apoptosis 
with concentrations up to 31.6 pg/cm2. At 100 pg/cm2, significant  FITC-PI staining was 
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Figure 4.3 Percent HAECs in each quadrant after  treatment with 10 nm SiC>2. HAECs were 
treated for  24 hours with silica nanoparticles, camptothecin or were untreated (UT). Data are 
representative of  all of  the data obtained from  the Annexin V flow  cytometer assay. Data are 
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Figure 4.4 Apoptosis in vascular cells treated with Si02. A. HAECs treated with 
Camptothecin (positive control) and increasing doses of  10 nm Si02 for  24 hours or were 
untreated (UT). B. HUVECs treated with Camptothecin (positive control) and 70 nm Si02 
for  24 hours. Data are represented as percent of  cells in the apoptotic quadrant. Each bar 
represents n=3. Statistically significant  changes (student's /-test, p<0.05) are identified  with 
an asterisk (*). 
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Figure 4.5 Apoptosis in BEAS-2B cells. Cells were untreated (UT) or were treated with 
increasing doses of  10 nm SiC>2, harvested at 24 hours and apoptosis measured. 
Camptothecin was used as a positive control. Data are represented as percent of  cells in the 
apoptotic quadrant (Q4). Statistically significant  changes (student's /-test, p<0.05) are 
identified  with an asterisk (*). 
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observed (data not shown), which meant that this high concentration killed most of  the lung 
cells. Therefore,  SiC>2 did not appear to cause apoptosis, but was cytotoxic at the highest 
concentration. 
The Role of  ROS in Apoptosis 
To investigate the role of  ROS in apoptosis, cells were pretreated with NAC, a 
metabolite of  the amino acid Cysteine. NAC acts directly as an antioxidant, reducing free 
radicals or is converted to L-cysteine, a precursor to glutathione, a potent antioxidant. The 
results from  pretreatment of  NAC before  a co-treatment with Si02 is shown in Figure 4.6. 
Experiments were performed  to determine the most effective,  nontoxic and nonapoptotic 
concentration of  NAC which was 5 mM (data not shown). Pretreatment with NAC 
ameliorated almost all of  the Si02-induced apoptosis. 
Discussion 
The studies in this chapter investigated the mechanism of  nanosilica-induced vascular 
cell damage. Amorphous nanosilica is the particle used through this dissertation because it 
was generally believed to be benign, and therefore  could potentially be useful  in many 
medical applications. This assumption appears to be valid for  the BEAS-2B lung cells, 
because silica did not significantly  induce cell death via any mechanism including apoptosis 
as measured by the Annexin V or PI staining, until a concentration of  100 pg/cm was 
applied. At these doses the cells stained positive for  both annexin and PI, indicating that the 
cells died via necrosis or were in the late stages of  apoptosis. However, since lower doses 
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Figure 4.6 Evaluating the role of  ROS in HAEC apoptosis. Cells were untreated (UT), 
treated with 10 nm Si02, or were treated with NAC then co-treated with 10 nm Si02 for  24 
hours. Camptothecin was used as a positive control. Data are represented as percent of  cells 
in the apoptotic quadrant. Each bar represents n=4 (n=2 from  2 independent passages). 
Results statistically significant  from  control are identified  with an asterisk (*) or from  Si02-
treated cells are identified  with a pound sign (#) (student's Mest, p<0.05). 
Many studies involving silica induced apoptosis in pulmonary cells have focused  on 
crystalline silica. These studies have shown a substantial induction of  apoptosis due to 
micron-sized crystalline silica treatment [115-118]. The study of  micron-sized crystalline 
silica is important to address occupational exposures and the etiology of  the well 
characterized syndrome known as silicosis. Since silicosis is a severe condition, evaluations 
of  the mechanisms of  cell damage may help prevent or treat the syndrome. One proposed 
mechanism in which particles causes apoptosis is through the production of  reactive oxygen 
species. Hu et al. showed that silica-induced apoptosis in alveolar macrophages is inhibited 
by the pretreatment of  cells with the antioxidants, NAC and rhodamine 6G [120]. This work 
is similar to ours only using a crystalline form  of  Si02 in alveolar macrophages. In addition 
to inhibiting apoptosis, they also showed that NAC inhibited silica-induced production of  IL-
1(3 and tumor necrosis factor  alpha [120]. 
While research into the cause of  silicosis is not directly related to the research 
presented here, the methodologies used to determine the cause of  apoptosis may translate to 
other particles and cell types. Current research by Santarelli et al. showed that HAECs 
treated with a-Quartz (Min-U-Sil 5) for  18 hours were positive for  FITC-conjugated annexin 
V and confirmed  their results using the Tunnel assay, another measurement of  apoptosis 
[119]. Their study also showed ROS generation induced by crystalline silica was inhibited 
by treatment with l,3-dimethyl-2-thiourea (DMTU), a hydroxyl radical scavenger [119]. 
Although the studies presented in this chapter utilized amorphous instead of  crystalline silica, 
significant  induction of  apoptosis was seen in both HAECs and HUVECs. In fact,  doses of  1 
pg/cm2 produced significant  apoptosis in HAECs equal to that of  the positive control. 
ROS is a common endpoint measured after  treatment with particles because the 
particle surface  itself  can facilitate  the production of  ROS, and particles can interact with 
cells to induce intra and extracellular ROS [82-85]. These observations do not hold true for 
every particle. In fact,  a recent study has shown that yttrium oxide and cerium oxide actually 
act as antioxidants in neurons [121]. 
Our studies showed pretreatment with NAC prior to exposure substantially reduced 
the percentage of  apoptotic cells staining positive for  apoptosis. This suggests that ROS is 
involved in apoptosis induced by silica nanoparticles. However, since the percentage of  cells 
staining positive for  apoptosis did not completely return to control levels, other mechanisms 
may contribute to the induction of  apoptosis. A future  direction for  this research would be to 
determine the site of  ROS generation, whether it be mitochondrial, lysosomal, or 
extracellular. Assays assessing the mitochondrial depolarization, a site of  ROS generation 
and signaling for  apoptosis, as well as caspase activation assays would give further  insight 
into the mechanism behind silica-induced ROS generation and apoptosis. The induction of 
antioxidant genes such as NQOl (NAD(P) H: quinone oxidoreductase), superoxide 
dismutase (SOD), heme oxygenase 1, and glutathione S-transferase  (GST) can be used as 
biomarkers for  the presence of  ROS. Induction of  these genes would indicate a sustained 
substantial presence of  reactive species which these genes might aid in detoxifying.  Analysis 
of  NQOl gene induction was performed.  However, preliminary results were inconclusive 
(data not shown). Inhibition of  ROS may also decrease the production of  proinflammatory 
cytokines as was seen by Hu et al. [120]. Additionally, other mechanisms of  apoptosis 
should be assessed such as particle induced DNA damage leading to apoptosis as well as 
testing more vascular cell lines to determine if  the results are specific  to HUVEC and HAEC 
cells. 
The data presented in this chapter show that treatment with amorphous nanosilica 
induces apoptosis in vascular cells. By showing that inhibition of  ROS formation  can 
ameliorate apoptosis, we have contributed to understanding how nanoparticles cause vascular 
cell death. With these exciting results, additional research can be conducted to further 
understand the toxicity of  nanoparticles and aid in producing a "safer"  formulation  that can 




Respiratory and cardiovascular morbidity and mortality are attributed to exposure 
to particles found  in environmental air pollution. With the advances in technology and 
the attractiveness of  nanoparticle chemistry, scientists have begun to introduce 
nanoparticles into various scientific  fields.  Already there are over 600 consumer 
products incorporating nanotechnology [11]. While inhaled micron-sized particles have 
long been correlated with lung disease and cardiovascular effects,  the specific  effects  of 
nanoparticles are largely understudied until recently. Nanoparticles may have vastly 
different  properties from  that of  closely related larger, micron-sized particles. Emerging 
human toxicological profiles  suggest both the potential for  unique therapeutic 
applications, as well as unusual adverse effects. 
The newest and most interesting uses for  nanoparticles are as medical diagnostic 
tools and carriers for  drug delivery. Metal oxide particles were used extensively in the 
studies presented in this document because they are not only present in air pollution, but 
they are also used 1) as components of  electronics; 2) as vehicles for  drug [16-18] and 
gene [19, 20] delivery in the biomedical field;  3) as imaging probes [21]; and 4) as 
disease diagnostic tools. 
Many reports on the adverse effects  of  nanoparticles have focused  on inhalation 
and associated lung diseases. However, these processes have yet to be fully 
characterized. Emerging evidence has shown that particles can translocate from  the lung 
to the systemic circulation [22, 24, 32-35]. Thus, it is vital to determine tissue 
distribution and toxicities of  these particles. Currently there is no clear method to 
determine organ-specific  exposures to adsorbed, inhaled, ingested or injected 
nanoparticles without specific  labels to detect their presence. We address this problem by 
modifying  the methodology of  field-flow  fractionation,  to provide a useful  new method 
to simultaneously quantitate nanoparticle amounts and determine size distribution. 
General exposure to particulates through inhalation, injection and ingestion 
provide routes for  contact of  nanoparticles with pulmonary epithelial, vascular 
endothelial and colorectal epithelial cells. Current research from  various groups has 
attempted to access particle toxicities in these organ systems. However, comprehensive 
direct comparisons have not been made because different  particulates and different 
biological materials and techniques have been utilized to measure common endpoints. In 
Chapters 3 and 4, concurrent cell culture experiments are performed  to directly compare 
cell types treated with the same particles, with the goals to determine the mechanism by 
which particles induce cellular damage and to rank the relative susceptibilities of  these 
three organs. 
Chapter 2 
In Chapter 2 the capability to detect nanoparticles and to simultaneously 
distinguish particle size distribution for  unlabeled SiC>2 in a sample of  mammalian lung 
tissue was demonstrated. Pre-existing techniques were used in combination, permitting 
separation of  particulates from  biological matrix. Isolating silicon dioxide from  liver and 
the more structurally complicated lung was a very important step in the overall analysis 
of  particle concentrations in tissue. The current methodologies for  the identification  and 
quantification  of  particles in tissue, fluorescence  microscopy and TEM, were compared 
to our sample analysis with the SdFFF instrument, demonstrating the usefulness  of 
microscopy to show particle interactions with cells, and to show the effectiveness  of  our 
enzyme digestion and particle separation techniques. SdFFF of  control particles 
suspended in surfactant  was used to generate a standard curve. The limit of  detection was 
7 x 1010 particles per injected sample using a light scattering detector. In the future, 
coupling the SdFFF instrument to ICP-MS would greatly enhance the sensitivity of 
detection, and could be used to determine the composition of  each peak from  a tissue 
sample. 
Our methodology is able to detect unlabeled Si02 nanoparticles isolated from  rat 
lung and liver tissue, but more importantly, is able separate a mixture of  silica 
nanoparticles with nominal diameters of  70 and 250 nm, illustrating the exciting 
capability of  the SdFFF methodology to detect nano- and submicron-sized particles from 
the same tissue in a single run with high resolution. The combination of  enzyme 
digestion of  tissue with particle sizing by SdFFF is a novel approach that will greatly 
facilitate  measurements of  natural and anthropogenic nanoparticles in laboratory 
toxicology studies, ecological systems, and human populations. This work introduces a 
new method to characterize the size distribution of  unlabeled inorganic particles in tissue, 
which will be beneficial  for  studies focused  on the cardiovascular effects  of 
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environmental and occupational exposures to an important class of  engineered 
nanomaterials. 
Chapter 3 
In Chapter 3, a complex matrix including multiple cell lines was used to assess 
the toxicity of  the metal oxide nanoparticles silicon dioxide, titanium dioxide, iron oxide, 
zinc oxide and cerium oxide. Previous studies have shown that metal oxide particles are 
not highly toxic or proinflammatory  in the pulmonary cell line, BEAS-2B [102]. An 
assay that measures mitochondrial function  to assess cellular viability showed a dose 
response to the metal oxide nanoparticles with the vascular endothelial cells, HAEC and 
HUVECs. The pulmonary (NHBE and BEAS-2B) and colorectal (CaCo-2 and RKO) 
epithelial cell lines were affected  by only the highest concentrations tested and loss of 
viability was rarely statistically significant.  The LD5o of  all of  the particles in all of  the 
cells showed that vascular cells were considerably more sensitive to metal oxide particle 
exposures with both micron-sized and nano-sized particles, in respect to cell death. Our 
results are consistent with other reports on effects  in the respiratory tract. The enhanced 
sensitivity of  vascular cells may be due to the difference  in cellular functions  compared to 
that of  pulmonary and colon cell lines. Vascular cells are not typically exposed to 
irritants and chemicals as frequently  as the cells of  the lung and colon which have direct 
contact with inhaled or ingested items. 
Cytokine production, a marker for  cellular risk, was assessed, providing 
additional evidence that vascular cells are more sensitive to metal oxide nanoparticles 
than pulmonary or colorectal cells. In terms of  the most likely applications of 
nanoparticle uses, enhanced sensitivity of  the vascular endothelium to particulates could 
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be particularly deleterious when metal oxide nanoparticles are used in the medical field, 
because these particles are most likely going to be injected and would encounter vascular 
cells frequently  and at high concentrations. Formulations of  nanoparticles used in the 
biomedical field  are being produced to enhance their safety.  However, since incidental 
and environmental metal oxide nanoparticles can be present in air pollution as a result of 
windblown dust, regulation of  their size, shape and chemistry is difficult.  The vascular 
effects  that we have shown may explain the increased cardiovascular morbidity and 
mortality observed after  exposure to high concentrations of  air pollution. 
Chapter 4 
In Chapter 4 the complex matrix of  experiments was simplified  to focus  on only 
one metal oxide nanoparticle with vascular and pulmonary cells. The purpose of 
simplifying  the experimental matrix was to investigate a mechanism by which a specific 
oxide nanoparticle, such as nanosilica, alters vascular cell function.  BEAS-2B cells 
showed only minor responses to silica in Chapter 3, which was consistent with the results 
in Chapter 4. Apoptosis did not become significant  in BEAS-2B cells (measured by 
Annexin V or PI staining) until a concentration of  100 pg/cm2 was used. Other forms  of 
silica have shown a substantial induction of  apoptosis in pulmonary cells [115-118], 
However, those silica forms  were not nano-sized and would not be used in most medical 
applications. 
Vascular cells, which responded significantly  to silica in Chapter 3, showed 
significant  induction of  apoptosis at low, near physiologically relevant concentrations. In 
addition, apoptosis, measured by the externalization of  PS, was prevented when vascular 
cells were pretreated with the antioxidant, NAC. Therefore,  one mechanism for  the 
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induction of  cellular death by nano-sized silica probably occurs through the formation  of 
ROS. 
Future Directions 
While this study has provided remarkable progress in the identification  and 
understanding of  nanoparticles, further  research is still required. The SdFFF data 
presented here showed that our tissue digestion followed  by SdFFF can be used to detect 
particles isolated from  tissues. However to fully  utilize this technique, additional 
characterization is required. The limit of  detection can be improved by using ICP-MS, 
permitting the determination of  particle concentration and particle composition. 
Additionally, understanding and preventing particle loss during tissue processing will be 
necessary to make this assay truly quantitative. The major goal is to expose an animal to 
particles and be able to isolate each tissue, precisely measuring deposited particle 
concentrations. 
Knowing the concentration of  particulates in tissue is important for  extrapolating 
in vivo exposures to in vitro studies. Our results show that vascular cells respond to 
nanosilica by the production of  proinflammatory  cytokines and the induction of  cellular 
apoptosis, which is preventable by pretreatment with an antioxidant. Future research 
should focus  on the link between all of  these effects  (ROS, apoptosis and inflammation). 
Previous studies with micron-sized crystalline particles have begun to investigate the link 
between apoptosis and ROS [120]. Modeling our studies after  their results may show 
similar patterns. Investigating the point in the signal transduction pathway that is 
activated and leads to apoptosis would permit us to understand the site of  particle-
induced alterations. One pathway to investigate is the activation of  the TNF-a receptor. 
As stated in Chapter 1, particles and ROS induce the production of  TNF-a, which can 
bind to the TNF-a receptor on the surface  of  a cell, and activate the external apoptosis 
pathway. 
Another future  direction for  this research would be to directly detect the presence 
of  ROS. Our initial studies showed that antioxidants were able to ameliorate apoptosis. 
However, we did not directly measure ROS. Changes in the gene induction of  GST, 
SOD, NQOl and many other antioxidant genes, using a reporter assay or quantitative 
real-time PCR could be used to identify  the presence of  ROS. Other techniques such as 
spin trapping will directly detect the presence of  free  radical components of  ROS. If  we 
confirm  ROS production, determination of  the site of  ROS generation, whether it is 
mitochondrial, lysosomal, or extracellular would be beneficial  and provide further 
mechanistic evidence that could link particle-induced ROS processes and apoptosis. 
Since our research has shown an increase in proinflammatory  cytokine production, 
determining the alteration of  these cytokines in the presence of  an antioxidant may yield 
important information  about the toxicity of  nanoparticles. 
Final Statement 
The work presented in this document contributed to the overall understanding of 
nanoparticles toxicology. A new method to identify  unlabeled inorganic nanoparticles in 
tissue was demonstrated and evidence was provided showing that vascular endothelial 
cells have enhanced sensitivity to metal oxide nanoparticles that may be mediated by the 
production of  ROS, leading to cellular apoptosis. Based on our results, the use of  nano-
sized Si02 in the biomedical field  may have serious consequences. Antioxidants are used 
in the treatment of  many diseases, and have been shown to inhibit particle-induced 
apoptosis in our studies. Therefore,  it is possible that antioxidants may be used as 
potential therapies for  persons exposed to high levels of  metal oxide nanoparticles. This 
body of  work has provided exciting new data that permits the progression and 
understanding of  nanoparticle toxicology. With continued efforts,  we may one day be 
able to fully  understand nanoparticles and their cellular effects,  and make them safe  for 
all of  the population. 
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